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2ABSTRACT
Fusion energy has the potential to be a safe and environ-
mentally favorable energy source. The importance of safety
necessitates the existence of a computer code having the capabil-
ity of assessing off-site impacts resulting from postulated fusion
reactor accidents. The FUSCRAC3 computer code has been
developed for this purpose. FUSCRAC3 calculates doses result-
ing from inhalation, groundshine, and cloudshine for 259 iso-
topes as well as doses resulting from ingestion for 145 isotopes.
FUSCRAC3's data base includes the most up-to-date dose
conversion factors for all four exposure pathways as well as the
most current environmental transfer factors for the ingestion
pathway.
This work presents a detailed description of the
modifications made to the existing fusion reactor accident code,
FUSCRAC2, in the development of the more advanced
FUSCRAC3 computer code. Also included is a report of the
validation procedures. Finally, the improved computer code
was applied in two ways: 1) to provide a general data base
presenting rem per curie data for each isotope, and 2) to assess
the doses resulting from possible releases from the reactors
evaluated in the ESECOM study. Regarding the latter
application, it was found that the general trends established in
the original study remained unchanged. However, it was
determined that the inclusion of the ingestion pathway
substantially affects the overall chronic dose. Isotopes of
particular interest due to the ingestion contribution include
H-3, Ca-45, Fe-55, and Po-210.
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81.0 INTRODUCTION
Fusion energy has the potential of offering many safety and environmental
advantages over current energy resources. One of the key issues in assessing its
environmental and safety characteristics is the analysis of off-site doses resulting
from postulated fusion-reactor accidents. The appropriate tool for such an
assessment is a computer code whose capabilities include modeling radioactive
plume dispersion, radiation exposure pathways, biological behavior of radionuclides,
and decay energies. FUSCRAC3 has these qualifications and can handle
essentially all fusion-related isotopes.
FUSCRAC3 has its roots in the CRAC (Calculation of Reactor Accident
Consequences) computer code. CRAC [1] was developed for the Reactor Safety
Study, WASH-1400 [2]. Sandia National Laboratories made improvements on
CRAC, accounting for emergency planning response as well as general risk
assessment, and called their modified version CRAC2 [3].
Prior to CRAC2, FUSCRAC was created at MIT, based on CRAC, but
which implemented a special model for tritium, as described in [4]. When the
CRAC2 code became available, the appropriate changes were made to FUSCRAC,
and FUSCRAC2 was created. No specific documentation existed for FUSCRAC2,
since the model used was already specified in [4].
FUSCRAC2 contained a data base that was still largely geared toward
fission. At the time this project was begun, FUSCRAC2 handled only 36
fusion-related isotopes. This posed great restrictions on the calculations of doses
received as a result of the release of activated reactor materials. Hence, one of
the major goals of this project was to expand the code's capabilities to 259
radioactive isotopes. Furthermore, the dose conversion factors for all four
9radiation exposure pathways (inhalation, cloudshine, groundshine, and ingestion)
needed to be updated to include the dose conversion factor data calculated by S.
Fetter [5]. (A brief description of those files used in this thesis is found in
Appendix A.) Also, an expanded set of environmental transfer factors computed
by A. Rood for 144 isotopes [6] needed to be included into the chronic section of
the input file of the computer code. The result of these modifications was
FUSCRAC3.
Several steps were taken in order to insure the validity of the new code.
These validation procedures are described in detail in Chapter 3.
It was then decided to establish a large data base consisting of rem/Ci data
for each isotope for worst case conditions using the new code. This was done,
and the results appear in Appendix D. The applicability of this data is very
broad, ranging from optimization of structural materials to specific safety analyses
for CIT (Compact Ignition Tokamak) and ITER (International Thermonuclear
Experimental Reactor).
A specific application is presented in Chapter 4, Section 2. It was decided
that a re-evaluation of the accident analysis study done by the Senior Committee
on Environmental Safety and Economic Aspects of Magnetic Fusion Energy
(ESECOM) [7] and [8] would be useful. Although it was expected that different
numbers would be obtained from the FUSCRAC3 code due to differences between
the code used in the ESECOM study and FUSCRAC3 (see 4.2.2), it was
nonetheless desirable to determine whether the general trends found by the
ESECOM study remained unchanged when FUSCRAC3 was applied.
The following chapters present the modifications made to FUSCRAC2 in
order to create FUSCRAC3, the validation procedure used to ensure its accuracy,
10
and its application both in generating a "generic" data base and in its specific use
for the ESECOM study.
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2.0 FUSCRAC3 MODIFICATIONS
2.1 Data Base Modifications
FUSDOS3 is the dose conversion factor (DCF) file utilized by the computer
code FUSCRAC3 to calculate doses. This data file contains information for three
of the four radiation exposure pathways: namely, inhalation, cloudshine, and
groundshine. The file was expanded to incorporate updated information for 259
isotopes, as computed by S. Fetter [5].
2.1.1 Inhalation Dose Conversion Factor Modifications
Fetter's data base contains internal dose conversion factors for 19 target
organs and nine irradiation times for 259 radionuclides. FUSCRAC3 handles 11
of these 19 organs which are thought to be most sensitive to radiation exposure.
These 11 organs are as follows: lung, bone marrow, stomach, small intestine,
upper large intestine, lower large intestine, skeleton, thyroid, testes, ovaries, and
whole body. Hence, information for some organs given by Fetter was not needed.
In addition to dose conversion factors for specific organs, Fetter gives data for the
whole body dose, the total body dose, and the effective dose equivalent. The
whole body dose is defined as the dose to the entire body calculated as if all
transformations were uniformly distributed throughout the body. The total body
dose is the mass weighted average of the dose to each organ. The effective dose
equivalent, or EDE, is the weighted average of the dose to certain organs, with
the weights being determined by the probabilistic risk factors for the generation of
fatal cancers associated with each organ. FUSCRAC3 uses the whole body dose
conversion factors, because the whole body dose is specified in regulatory limits.
In calculating acute effects, one must consider the critical time period, which
is defined as that time period over which the dose must be delivered in order for
12
an effect to be seen. In the CRAC2 [3] model, this critical time period is
organ-dependent. For the whole body, tests, ovaries, and thyroid, the critical
time period is two days. For the bone marrow, skeleton, and gastro-intestinal
tract, it is seven days. And for the lungs, it is one year. It is important to
note that other models may consider different time periods as being critical. For
example, in FUSEDOSE [9], S. Fetter uses the whole body dose in the first seven
days plus one half the dose in the next 23 days as his critical time period for
determining acute effects to the whole body.
Fetter's data for the inhalation dose conversion factors was expressed as the
total exposure (rem) from inhaling a given quantity of radioactivity (Ci)
integrated over nine time periods after inhalation (and including the contribution
from radioactive daughters). These nine time periods include four acute time
periods (0-2 days, 0-7 days, 0-30 days, and 0-1 year), and five longer time
periods (0-10 years, 0-20 years, 0-30 years, 0-40 years, and 0-50 years).
FUSCRAC3 requires only seven time periods: 0-acute time period (organ
dependent), 0-1 year, 1-10 years, 10-20 years, 20-30 years, 30-40 years, and
40-50 years. Hence, the proper time periods for each organ had to be selected
from Fetter's data base, and the dose conversion factors from Fetter's data for
the 0-10, 0-20, 0-30, 0-40, and 0-50 year time periods had to be subtracted
successively to generate 1-10, 10-20, 20-30, 30-40, and 40-50 year time period
information required for FUSCRAC3.
The above modifications were carried out in three steps using simple
computer codes. The first code, STEP1, selected the data for the 11 organs of
interest to FUSCRAC3, and created a temporary data file called "first." STEP2,
the second computer code, selected the appropriate acute time period for each
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organ as well as the 0-1, 0-10, 0-20, 0-30, 0-40, and 0-50 year information and
stored the data in a temporary file called "second." Finally, the adjustment from
the cumulative time period format of Fetter's data to the differential format of
FUSCRAC3 was made in STEP5, which is the computer code that creates
FUSDOS3. (See 2.1.4.) All of the above-mentioned codes are found in Appendix
B.
2.1.2 Cloudshine Dose Conversion Factor Modifications
For cloudshine exposure, Fetter provides a dose rate conversion factor (rem/s
per Ci/m 2 ) for 21 target organs and 259 radioactive isotopes. FUSCRAC3
requires a dose rate conversion factor (also in rem/s per Ci/m 2 ) for its 11 organs
of interest. Hence, the STEP3 computer code was written in order to select the
appropriate data from Fetter's files and then to create a temporary cloudshine
data file called "third." (Again, see Appendix B.)
2.1.3 Groundshine Dose Conversion Factor Modifications
For groundshine exposure, Fetter provided a dose rate conversion factor
(rem/s per Ci/m 2 ). FUSCRAC3 requires three numbers, one of them being a
dose rate conversion factor (in rem/yr per Ci/m 2 ). In addition to this number,
FUSCRAC3 requires two additional numbers for its early effects calculations: the
integrated groundshine dose conversion factors for the first eight hours and for the
first seven days. FUSCRAC3 uses these two numbers combined with a user-input
time period over which the prompt groundshine exposure is to take place. This
user input time period should lie between eight hours and seven days, because the
code uses an interpolation routine based on the integrated groundshine at 8 hours
and at 7 days. It is recommended that a time period of 7 days be chosen.
That way, a conservative prompt groundshine dose is calculated. Furthermore, for
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all organs except lung, this would not adversely affect the "prompt" dose period,
which, for all organs except the lung, is either 2 or 7 days.
Because a decaying nuclide may form a radioactive daughter (and grand-
daughter), the dose due to the decay of these species must be included in the
total integrated groundshine dose conversion factors, because FUSCRAC3 does not
keep track of decay products once the isotope has been deposited on the ground.
Furthermore, a decaying nuclide may have more than one decay pathway
associated with it. Thus, for each isotope, one must keep track of decay
pathways and their associated probabilities, as well as of the buildup of
radioactive daughters and granddaughters over the time period of interest, in
order to correctly calculate the integrated dose conversion factors.
The first step in these groundshine calculations involved the creation of an
extensive data file called hflife2, using information from [9] and [10]. For each of
the 259 isotopes, hflife2 lists the isotope's halflife, number of branches (up to 2),
branching percent, number of radioactive daughters in each branch (up to 2, the
second daughter being equivalent to a granddaughter), and the daughter(s)
halflife(s).
The next step was the writing of a computer code (STEP4GD) which would
implement the data from hflife2 in order to calculate the integrated doses. The
logic of the calculations is presented in the flowchart in Figure 2.1.
The following numerical methods were incorporated into the code to insure
accuracy:
1) exp(--At) was written as 1/exp(At) in order to prevent smearing, or
catastrophic cancellation, as At gets large. (A is the decay constant,
and it equals In2/half-life)
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FIGURE 2.1
LOGIC OF INTEGRATED GROUNDSHINE DCF CALCULATIONS
isotope,organ
dose dose dose dose dose ds
from c I -bfo ranc+h ~ 4f a
parent duger rad- parent daug er grand-d ughter au ter
branch 1 dose branch 2 dose
Total dose = branch 1 probabity * branch 1 dose +
branch 2 probability * branch 2 dose
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2) The expression 1 [1 -- At can cause problems if the difference is
close to 0 i.e., if A is small, or, in other words, if the half-life is
large). Even on large computers, 0 is often returned instead of 10-5
or 10 , etc. This can cause significant numerical errors because the
difference is being divided by A, which is a very small number.
Thus, letting x = e At, one rewrites (1-x) in the following way:
(1-x) = 1-x 1 + 1-x 2 1-X2  1+x 2  (2.1)1+X) (1+) 
- +xj 1+x2
1-x4
-x x2+x+1
One could keep going, but this is far enough.
Since x is always less than one, x4 will be even less than x. Hence, the
difference between 1 and x4 is greater than the difference between 1 and x, and
should be great enough to return to a non-0 value.
It was determined that there is still a problem for one isotope, even with
the improved expression from Equation (2.1). That isotope is La-138 which has
a half-life of 3.47 x 1018 seconds, or approximately 110 G yr. The computer still
returns a 0 value for the eight-hour time period (a calculator does also).
However, the computer does return a non-zero answer for the difference expression
for the seven-day time period, and because A is so small, the dose is significant
(on the order of 103 rem/Ci/m 2).
Because La-138 is not an important fusion isotope in general, the expression
in Equation (1) was kept. If it is desired in the future, it may be possible to
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get a more accurate dose for the eight-hour time period by expanding the
numerical expression further:
1-x 4  1+x 4  - 6 1-x 8I 3- 2 X (2.2)
x3+x2+x+1 1+x x7 +x+x5 4 x3+x 2 +x+1
Incorporation of this expression into STEP4GD would require much care, and
would also generate a more lengthy and more involved code.
The doses resulting from the parent isotope, its daughter(s), (up to two
corresponding to the two possible branches) and its granddaughter(s) (up to two
corresponding to the two possible branches) are calculated by the code using the
following equations (Note: "p" refers to parent; "D " and "1" refer to daughter;
"D2" and "2" refer to granddaughter):
Dose Due to Parent:
P = P e pt P = atoms (2.3a)
-A t
PAP =P0e P - A = Ci/m 2  (2.3b)
G = rem s (2.3c)
P Ci /M
-A tP A e t - G = rem/s (2.3d)
rem /s = G e (2.3e)
Ci / m2 P
t~ -A t G F -A ti
Integrated dose: G e - = 1 - eA PJ rem/Ci/m 2  (2.3f)
P p
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Dose Due to Daughter of Parent
-A t
Di - AP=-PeAe 9
Solution of this equation:
AD t
D e 1
POA e [AD~ AP t
S D1 p + C
Initial condition: At t=O, D1 = 0
Therefore, C = 0
DI p
P A
Thus, D1 (t) = 0 -Apt
AP 0 -A [Apt - eAD t]
Dp
And
P 0 pAD 1
D AD = AD A
So
Ci/m 2 )daughteri-
(Ci/m 2 )p a rent deposited
AD
And
e-A pt
[ -A Pte
P 0  e~AD t
D 1 p
at o ms
mT
-eA Dt Cida hter1
Di
o p
-AD 1t
GD A D 
-Apt 
-ADt
A I e e t1 1 Pi 
e
rem/s (C i /I 2-daughter_ rem/s
7(0) d aughteri (Ul/Mi2)parent (U/in ) p arent
dD 1
T D (2.4a)
(2.4b)
(2.4c)
(2.4d)
(2.4e)
(2.4f)
(2.4g)
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Thus, integrating, one finds:
t=8hrs,7days
0
GD AD -A t
dt 1 1 e
CD AD
Ap I DS ~ Ap 1
S1- e-A pt
GD
1AD1 p7
Dose due to Granddaughter of Parent:
dD2
T = 1D D
dD
2
djt
- D2AD2
+ D2 AD2 = D ADi
I p D1
D p T
P0ApA A- t
AD 1 A D2 A T
eLD2 AD t1
eAD 2- D j + C (2.5c)
Initial condition: At t=O, D2 =0.
T herefore, C = D2 A D D 2AD A I7P1x
Thus, D2 (t) = PA 
-AD 1t
[AD2 D LAD 1p
+
-A t
AD 2 e
- AD t
D 1 e 2
D2~ AD e 2
GDA D
D A
-AD t
e D1 (2.4h)
1 - (
L -A pt
Solving:
AD2t
D2 2
- AD t
-ei1
(2.5a)
(2.5b)
(2.5d)
(2.5e)
at o ms
-Dt
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Thus:
D -Ap 
t
D2 2 o p 2 [ADi- AP] [AD 2 AP1
-AD t
AD e
D2 D D, ~pJ
So,
+
D2 A2 _ Ci / m 2 d aught er2
~ C i /m parent
-A t
AD e
- 2 [AD Ap LA 2 - p
~ A2 t
AD AD
D2 1D D2 T-
(2. 5g)
AD t
AD e 1
[AD 2 -D J [AD- Ap
AD e
-A2 t 1
LAD 2 - AD LAD 2 - Ajj
Finally, integrating yields:
K D AD eApt
GD2 LAD p- A D22
-AD t
ADAD e 2
AD2 ~ AD1 D dt
AD2
-A t
ADe
D1D
(2.5f)
+
Ap+[D2
21
AD AD 
-A
= GD A AD- 2A-1  [1 - e- P (2.5h)
2 p A D AP [AD2  'J
D2 I 2_
A 2 D 2pD2 j LAD, - ApJ
AD1  [2ADt1
I D2 - AD [AD2- A -]
See Appendix B for a listing of the STEP4GD computer code. (A list of variable
names is also included in Appendix B.) The groundshine dose conversion factor
information generated by STEP4GD was placed in a file called "fourth."
2.1.4 Creation of FUSDOS3
The final step in the creation of the updated dose conversion factor file for
FUSCRAC3 was to combine the data from "second" (inhalation), "third"
(cloudshine), and "fourth" (groundshine) data files. This was accomplished by the
computer code STEP5 listed in Appendix B, which wrote to "fdtrl", which, after
validation, became "fusdos3."
2.2 Input File (FUS.I) Modifications
2.2.1 Chronic Dose Section
The chronic section of the input file is broken up into six pathways. The
first pathway accounts for resuspension of inhaled nuclides and concerns all 259
radionuclides. The sixth pathway involves the chronic groundshine dose and also
concerns all 259 radionuclides. Pathways 2 through 5 represent the ingestion
exposure pathway. Pathway 2 deals with the direct ingestion of crops; pathway 3
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involves the direct ingestion of milk; pathway 4 concerns the direct ingestion of
beef; and pathway 5 deals with two modes of indirect ingestion: indirect
ingestion of crops, and the sum of indirect ingestion of beef and of milk.
In order to model the ingestion exposure pathway, one must model the
transfer of radionuclides in the food chain, and hence, one must have an
environmental transfer factor data base, as provided by A. Rood in [6]. These
factors relate the quantity of a radionuclide ingested from crops, beef, and milk to
the concentration of radioactivity on the ground after plume passage (Ci
ingested/Ci deposited/m 2). Only 145 of the 259 radionuclides were considered
important in the food chain model. The others were considered unimportant
because they were gaseous, or they were too short-lived (half-life < 10 minutes),
or they were metabolically insignificant. The environmental transfer factors for
the 144 of the 145 isotopes were provided by A. Rood [6]. The factors for
tritium were provided by S. Piet [4]. For a flowchart representation of Rood's
environmental transfer model, see Figure 2.2.
As is seen in Figure 2.2, the direct pathway considers radioactivity that
directly falls onto crops and grass. Radioactivity can then be ingested by man
eating contaminated crops, or by eating contaminated beef or milk obtained from
cows that fed on contaminated grass. The indirect ingestion pathway considers
radioactivity that first enters the soil and is then indirectly passed into crops or
grass by root uptake. Rood [6] determined the direct and indirect transfer factors
for two time periods: 0-1 year and 0-infinity. This latter time period actually
has a cutoff point when the quantity of radioactivity that would be ingested
becomes negligible because of losses to the soil sink or to radioactive decay. For
the direct pathway, the transfer factors for the two time periods are the same
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FIGURE 2.2
FLOWCHART OF ROOD'S ENVIRONMENTAL TRANSFER FACTOR MODEL
Source Term
(C i /m2)
rops Crops rQass Gross
I d rDt i rec t i D rect I nd irec t
ni r Ci/m2 D* C Ci/m2 Ci n/r2
D** A* D**
Soil Roots 0
C Fi/m2 C Ci/m2 '
D**
Sink
Ci/m2
C Mk Beef Milk Beef
Direct Direct sInddi rec I eqivet in ect-
me n Ci/L Ci/kg Ceie/L Ci/kDrf to lrd
CF I C CF CF CIF
Indirect Direct Direct Direct Indirect Indirect
Crops* Crops* Milk* Beef* Ml* Beef*
*CF is the conversions faco ivnn untsof
meaning to the environmental transfer factor.
*D refers to losses due to radioactive decay.
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since this pathway represents crops and grass during the first growing season.
For the indirect pathways, the two values are different, but are close for
short-lived isotopes. The zero to infinity values were chosen for FUSCRAC3.
Tritium is different from all other isotopes. Plants immersed in air with
tritiated water vapor exchange water with the air humidity quickly. As a result,
the direct ingestion exposure pathway for tritium is related to the air
concentration during plume passage rather than to the integrated ground
concentration, and the environmental transfer factors for direct ingestion are thus
inversely proportional to both the absolute humidity (g/m 3) and the deposition
velocity (m/sec). For direct pathways, tritium is lost through transpiration from
the plant, with a half-life of about one day. This value has been hard-wired
into the code and is used in calculating an effective half life. For the indirect
pathways, tritium is lost to the soil sink at a slow rate of 4%/year, which
corresponds to a half-life of 6,325 days. This value was hard-wired into the
FUSCRAC3 code by S. Piet [11], and it is combined with the radiological
half-life for tritium to determine an effective half-life for the indirect pathways.
Furthermore, indirect ingestion dominates direct ingestion for tritium because root
uptake of ground water is faster and more efficient than uptake of ground
contamination. This has also been accounted for. It was also discovered by S.
Piet and S. Brereton that there was an error in the assumed value of the soil
moisture content used to determine the indirect transfer factors for tritium [11J.
The value, 105 ml/m 3, corresponded to a moisture content of only 0.0105% on a
volume basis. -In recent tritium release experiments, soil moisture content was
measured in the range from 12-25% on a volume basis. Hence, the indirect
factors were recalculated by Piet and Brereton and yielded numbers that were
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three orders of magnitude lower. These numbers have been incorporated into the
chronic section of the input file. For further details on the tritium model, one
should consult [4] and [11].
In addition to the environmental transfer factors provided by [4] and [6],
Fetter [5] provided the ingestion dose conversion factors for 19 organs, expressed
in rem/Ci inhaled, integrated over nine time periods (0-2 days, 0-7 days, 0-30
days, 0-1 year, 0-10 years, 0-20 years, 0-30 years, 0-40 years, and 0-50 years).
FUS.I requires six time periods, the first being the time period for integrating
exposure after an isotope is ingested. It is recommended that this value be set to
0-50 years. The next five time periods are 0-10 years, 10-20 years, 20-30 years,
30-40 years, 40-50 years. The STEP6 computer code was written to extract the
necessary information for the 11 isotopes from Fetter's ingestion dose conversion
factor files, and also to generate differential time-period information presented by
Fetter. STEP6 created a temporary file called "ingest".
Each of the six exposure pathways in the chronic section of FUS.I also asks
for a time period (in days) and a radiation limit (in rem) to be used for an
interdiction test. The code actually only tests for interdiction for direct
ingestion and for groundshine [11]. It is recommended that a time period of 50
years (18250 days) be used which corresponds to the "0-ao" integrated
environmental transfer factors [6], Furthermore, it is recommended that a high
radiation limit (250 rem) be used to avoid interdiction. That way, the dose
reported would be the most conservative dose incurred (i.e., without any food
destruction). -
The SETUP computer code combined the information from "ingest" and
Rood's data files to generate the new chronic section of the input file. (See
26
Appendix B for listings of STEP6 and SETUP.) Tritium values were entered by
hand, using [4].
2.2.2 Isotope Section
The input file was expanded to contain release information and half-lives of
259 isotopes. There is one important fact that a FUSCRAC3 user must be aware
of regarding the isotope section of the input file. The isotope section of FUS.I
asks for the name of the parent of the isotope if the parent is radioactive.
However, some isotopes have more than one parent, and FUSCRAC3 cannot
handle more than one parent. For those isotopes with more than one parent, the
parent with the shorter half-life was chosen for all cases except one (the parent
of Ta-179 was chosen to be W-179 instead of W-179m). Table 2.1 presents a
list of those isotopes with more than one parent. If a user should decide to use
parent 2 from the list instead of parent 1 for whatever reasons (structural
components, for example), he just needs to go into the isotope section of the
input file and replace the current parent with the new parent.
2.3 Modifications Made to the Main Code (FUSCRAC3)
2.3.1 Array Expansion
The major modification to the code itself was the enlargement of existing
arrays to contain the larger amount of information. Arrays concerning isotopes
were expanded from 54 to 259 while arrays concerning organs were changed from
either 13 to 11 or eight to 11. However, many organ arrays set at eight were
kept at eight, because that number reflects the limit on the number of effects in
the acute and latent categories, which is hard-wired into the code itself.
2.3.2 Creation of FUSFET.0 Output Files
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Table 2.1. ISOTOPES WITH MORE THAN ONE PARENT
Isotope Parent 1 Parent 2
sc-44
y- 90
y- 9 1
nb-93m
nb-95
nb-97
nb-91
tc-99
te-129
i-129
i-131
sm-146
ta-182
ta-179
re-188
sc-44m
y-90M
y-91m
mo-93
nb-95m
nb-97m
mo-91
tc-99m
sb-129
te-129
te-131
pm-146
ta-182m
w-179
re-188m
t i-44
sr-90
sr-91
zr-93
zr-95
zr-97
nb-91m
mo-99
te-129m
te-129m
te-131m
gd-150
hf-182
w-179m
w-188
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Because FUSCRAC3 was to be used to generate rem/Ci data for all 259
isotopes for a pessimistic fusion reactor accident scenario (see Chapter 4), it was
desirable to add to the code the ability to create a separate output file for each
isotope consisting only of the applicable data. The information needed was as
follows: 1) acute effects, latent effects from early exposure, and latent effects
from chronic exposure at 1 km; 2) latent effects from early exposure and latent
effects from chronic exposure at 10 km; 3) total number of cancers from early and
chronic exposure (total latent/total); 4) total number of cancers calculated as if
the whole body were a single organ, instead of treating it as a sum of individual
organs with their organ-specific dose factors, as in 3); and 5) total whole body
man rem.
Appendix C contains a partial code listing where additions were made to
create the output file, FUSFET.O. The additions are indicated with an asterisk.
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3.0 VALIDATION
3.1 Checking of Data Manipulation
Because much of the modifications described in Chapter 2 involved extensive
data file manipulation and modification, several validation checks were made to
insure that the data was processed properly.
3.1.1 Inhalation and Cloudshine
After the data file "first" was created, spot checks were performed on
several isotopes against the original Fetter files [5] to verify that the dose
conversion factor for a specific organ and isotope ended up where expected. After
the data file "second" was generated, similar spot checks were again conducted by
comparing "second" to the original Fetter files. Similar checks were made for
"third," the data file for cloudshine.
3.1.2 Groundshine
Hand calculations were performed for several isotopes to confirm that the
computer code, STEP4GD, was calculating the eight-hour and seven-day
integrated groundshine dose conversion factors correctly. Hand calculations were
performed for H-3, whose dose is due only to itself; Mg-28, whose dose results
from its daughter (Al-28) and itself; Ar-42, whose dose results only from its
daughter (K-42) because Ar-42 is a noble gas and hence has zero deposition
velocity; and Sr-91, which has two branches, the first branch yielding two
daughters (y-91m and y-91), and the second branch resulting in one daughter
(y-91). Furthermore, each calculation checked a different organ: marrow for h-3;
stomach for Mg-28; testes for Ar-42; and lung for Sr-91. All hand calculations
agreed with the code-generated values within three significant figures.
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3.1.3 Final FUSDOS3 File
Once all of the dose conversion factor data had been entered into the
FUSDOS3 dose conversion file, spot checks performed on several isotopes and
organs to ensure that the data was in the correct location.
3.1.4 Ingestion
Spot checks were performed on several isotopes in the ingestion section of
the input file. For every isotope checked, every environmental transfer factor was
checked against the original Rood files [6], and every dose conversion factor for
every organ was checked against the original Fetter files [5].
3.2 Code Validation via Comparison of FUSCRAC3 with FUSCRAC2
The basic principle behind the code validation procedure was that the dose
calculated by FUSCRAC3 resulting from a single isotope for a single exposure
pathway should be equal to the dose calculated by FUSCRAC2 multiplied by the
ratio of the new dose conversion factor to the old dose conversion factor for that
isotope pathway.
For each isotope that was checked, the following procedure was implemented:
1) Six computer runs were generated as follows:
i) Inhalation pathway only: All groundshine and cloudshine dose
conversion factors were set to zero in the FUSDOS3 file and all
ingestion concentration factors were set to zero (actually, they
were set to 10~9 to avoid division by zero errors).
Inhalation-only runs were generated by FUSCRAC3 and
FUSCRAC2.
ii) Groundshine pathway only: All inhalation and cloudshine dose
conversion factors were set to zero in the FUSDOS3 file, and all
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ingestion concentration factors were set to zero (109 ).
Groundshine-only runs were generated by FUSCRAC3 and
FUSCRAC2.
iii) Complete runs: Runs were generated by FUSCRAC3 and
FUSCRAC2, in which all pathways were included.
2) Acute Effects Validation
i) Inhalation: The complete runs (iii) from FUSCRAC3 and
FUSCRAC2 were used, because the output file breaks down the
total acute dose into the contribution from each of the acute
pathways (inhalation, groundshine, and cloudshine). The ratio of
the FUSCRAC3 inhalation dose to the FUSCRAC2 inhalation
dose should equal:
Ratio = new DCF for tacute
old DCF for tacute
where tacute is the time period for acute exposure, as discussed in
2.1.1 (tacute = 2 days for thyroid, whole body, ovaries, and testes; 7
days for marrow, skeleton, stomach wall, small intestine, upper large
intestine, and lower large intestine; and 1 year for the lung).
Calculations were performed for H-3, Mn-54, Fe-55, Fe-59, and
y-91 for every organ. All inhalation results from the codes
compared well (within 2%). (Remember that FUSCRAC2 only
handled 36 isotopes.)
ii) Groundshine: groundshine doses were compared in a similar
- manner to those of inhalation. The results compared well (within
2%) when the ratio of dose rate conversion factors (rem/yr per
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Ci/m 2 ) was applied. The comparisons were made using the same
isotopes as those listed under the inhalation section.
iii) Cloudshine: Cloudshine doses were compared in a similar manner
to those of the groundshine. Comparisons using the ratio of dose
rate conversion factors (rem/s per Ci/m 3 ) yielded excellent
agreement (within 2%).
3) Latent Effects from Early Exposure Validation
i) Inhalation: The "inhalation only" computer runs were used for
this comparison. It was found that the ratio of FUSCRAC3
doses to FUSCRAC2 doses equaled the ratio of the 0-50 year
inhalation dose conversion factors (within 2%). The same
isotopes used in the acute validation were compared (H-3,
Mn-54, Fee-55, Fe-59, y-91).
Initially there was thought to be a problem with the Fe-55
latent dose to the thyroid because it was found that the ratio of
doses from FUSCRAC3 and FUSCRAC2 did not equal the ratio
of the 0-50 year inhalation dose conversion factors. Several
checks were carried out to ensure that the data was indeed being
read and manipulated correctly, and that the code itself was
functioning correctly. Careful scrutiny of the code itself revealed
special treatment of the thyroid in the latent effects subroutine:
only the 0-1 dose conversion factor for latent effects due to
initial exposure is used. The original authors of CRAC2 [3]
implemented this special thyroid treatment because of the type of
health effect that occurs with the thyroid . This problem was
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not seen for the other isotopes because most, if not all, of the
dose contributing to latent effects occurs within the first year for
those isotopes. However, for Fe-55, the 1-10 year DCF is about
one and a half times greater than the 0-1 year value. When the
ratio of 0-1 year DCF's was used, excellent agreement (within
2%) was found.
ii) Groundshine: This validation utilized the "groundshine-only"
computer runs. Again, excellent results were achieved (within
2%) when the ratio of seven-day integrated groundshine dose
conversion factors was applied.
iii) Cloudshine: Cloudshine calculations were not performed because
the cloudshine dose contribution to latent effects is negligible.
iv) The sum of the "inhalation-only" dose to an organ and the
"groundshine-only" dose to that organ should equal the total
initial dose to that organ in the complete run. (A slight
difference is allowed, accounting for the exclusion of cloudshine.)
It was found that the sum did indeed equal the total for every
organ for every isotope listed above (within 2%).
4) Latent effects from Chronic Exposure
The latent effects from chronic exposure were checked by setting the
inhalation, ground, and cloud dose conversion factors to zero for the
isotope being checked. The environmental transfer factors were set to
one,- and the ingestion dose conversion factors for all but the pathway
of interest were set to zero. The total dose would then be from that
one particular ingestion pathway only. The ratio of the doses from
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FUSCRAC3 and FUSCRAC2 were found to agree with the ratio of the
ingestion dose conversion factors (within a few percent) for H-3, Fe-55,
and Co-60. (All four ingestion pathways were checked.)
3.3 Additional Validation: Comparison of FUSCRAC3 with FUSCRAC2 for a
Specific Accident Scenario
Comparison runs were conducted using the Loss of Coolant Accident
(LOCA) data presented in Brereton's Ph.D. thesis [12]. The deuterium-tritium
design was chosen, with the plasma beta equal to 10%.
The relevant release characteristics are presented in Table 3.1, as are the
isotopes which were released*.
3.3.1 Differences in the Chronic Dose Calculations
FUSCRAC2 had the capability of handling only four of the released isotopes
in its chronic section: Cr-51, Mn-56, Fe-55, and Ni-57. In addition to these
four isotopes, FUSCRAC3 also handles the following isotopes in its chronic
section: P-32, P-33, V-48, V-49, Cr-49, Mn-52, Mn-52m, Mn-54, Fe-59, Ni-59,
Ni-63, Ni-65, Mo-93, Mo-93m, Mo-99, Mo-101, W-181, W-185, and W-187.
Also, FUSCRAC2 contained ingestion dose conversion factors for the whole body
only, whereas FUSCRAC3 contains ingestion dose conversion factors for all eleven
organs. Hence, it was expected that FUSCRAC3 would calculate a much larger
contribution to the total latent effects due to ingestion.
It was instructive to compare the whole body ingestion dose conversion
factors and the environmental transfer factors for each ingestion pathway for those
four isotopes that FUSCRAC2 could handle. Table 3.2 presents a summary of
such a comparison. It is seen that the biggest difference in environmental
transfer factors occurs in the crops' direct and indirect values. In each case, the
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Table 3.1. RELEASE CHARACTERISTICS OF
THE LOSS OF COOLANT ACCIDENT SCENARIO [12]
Type of reactor: Deuterium-Tritium
Plasma beta: 10%
Pasquill stability class: D
Windspeed: 5 m/s
Release height: 0 m
Population density: 260 mi 2 (100 kM2 )
Immediate release; 10 hour duration
Building height: 50 m; building length: 100 m
Isotopes released:
p-32* cr-51 fe-55 mo-93m*
p-33* cr-55*x fe-59t mo-99f
ti-51*x mn-52* ni-57 mo-101*
v-48* mo-52m* ni-59* w-181*
v-491 mn-54t ni-63I w-185*
v-52* mn-56 ni-65* w-187*
v-53* mn-57*x mo-91*X
cr-49t fe-53*x mo-93t
*FUSCRAC2 does not handle this isotope; FUSCRAC3 does.
tFUSCRAC2 handles this isotope for acute exposure and latent effects from initial
exposure calculations, but the input file for FUSCRAC2 does not include this
isotope in any of the six exposure pathways in the chronic section. This isotope
is handled by FUSCRAC3 in all six chronic exposure pathways.
xFUSCRAC3 calculates the resuspension and groundshine contributions to the
chronic dose for this isotope, but it does not calculate any ingestion dose for this
isotope.
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new FUSCRAC value (i.e., the value calculated by A. Rood in [6]) is
approximately 9.6 times higher than the old FUSCRAC2 value. In fact, on page
14 of his report [6], A. Rood states, "FUSCRAC CF crop values were higher by
a factor of about 10 when compared with the corresponding FUSECAL CF
values" (where CF stands for the concentration factor and is equivalent in
meaning to the environmental transfer factor). It is believed that Rood meant
"lower", not "higher", in his statement, because the tables on pages 15 through
22 of his report reveal that each FUSECAL CF crop direct and indirect value
(which was used in the updated FUSCRAC3) is approximately ten times greater
than the corresponding FUSCRAC2 value.
Table 3.2 also shows a significant difference in the whole body ingestion
dose conversion factors for Cr-51. The FUSCRAC3 value is approximately 1/14
the FUSCRAC2 value. Also, there are no other large differences in the other
environmental transfer factors (i.e., beef and milk).
The comparisons in the results from FUSCRAC3 and FUSCRAC2 were
made on three levels: acute effects, latent effects from early exposure, and latent
effects from chronic exposure.
3.3.2 Acute Effects
The inhalation, groundshine, and cloudshine doses calculated by FUSCRAC3
were greater than those calculated by FUSCRAC2 for every organ in the acute
section (i.e., lower large intestine, marrow, lung, and whole body). The most
dramatic difference occurred in the inhalation dose, where FUSCRAC3 calculated
a dose which was 315 times higher for the marrow, 53 times higher for the lower
large intestine, 6.9 times higher for the lung, and 66 times higher for the whole
body. The results are simply explained by the fact that FUSCRAC3 handles so
38
many more isotopes than FUSCRAC2. For those isotopes which both
FUSCRAC3 and FUSCRAC2 handle, the air concentrations calculated by each
code were the same. However, there were so many more isotopes in the air that
FUSCRAC2 could not handle. Of particular importance because of the magnitude
of their activity at the time of release were: P-32 with a half-life of 14 days
and an inventory of 6100 Ci; P-33 with a 25-day half-life and an inventory of 63
Ci; W-181 with a half-life of 122 days and an inventory of 290 Ci; W-185 with
a 75-day half-life and 372 Ci inventory; and W-187 with a one-day half-life and
79 Ci inventory (none of these isotopes could be handled by FUSCRAC2).
Analysis of the above inventories leads to an explanation of why the lung
inhalation dose showed a relative increase from FUSCRAC2 to FUSCRAC3 which
was much smaller than that exhibited by the other organs. The acute time
period for the lung is one year. All of the above-mentioned isotopes have
half-lives of less than one year, and hence, most of their contribution to the dose
to the lung will occur in the first 30-80 days. Fe-55, on the other hand, has a
half-life of 985 days, so it is a significant contributor to the dose over the entire
time period. However, the inhalation dose conversion factor to the lung for Fe-55
in FUSCRAC3 is roughly one-half the inhalation dose conversion factor to the
lung in FUSCRAC2. And because Fe-55 has an inventory of 680 Ci at the time
of release, it is certainly one of the more important isotopes. Therefore, one can
conclude that the reduction by one-half of the Fe-55 inhalation dose conversion
factor to the lung counteracts all of the additional isotopes considered by
FUSCRAC3 by a large amount, resulting in an overall lung inhalation dose
increase on the order of only a factor of 7.
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On the other hand, the bone marrow has an acute time period of seven
days. Hence, the major isotopes contributing to its dose are P-32, P-33, and
W-187. P-32 has as its largest dose conversion factor the marrow dose
conversion factor, and since P-32 also has the largest activity at the time of
release (by far), this explains why the marrow dose given by FUSCRAC3 is 315
times higher than that given by FUSCRAC2.
3.3.3 Latent Effects from Initial Exposure
FUSCRAC3 computed doses which were larger than those computed by
FUSCRAC2 for all effects: 12 times higher for leukemia; 2 times higher for lung
cancer; 4 times higher for gastro-intestinal cancer; 1.3 times higher for thyroid
cancer; 12 times higher for bone cancer; and 3 times higher for cancer to the
whole body.
The increase is due, of course, to the capability of FUSCRAC3 to handle all
of the isotopes. The reason that the increase is not very large is again because
of Fe-55. This time, it is the seven-day integrated groundshine dose conversion
factors which are lower in FUSCRAC3 than they are in FUSCRAC2. In fact, for
each organ, the groundshine dose conversion factor for Fe-55 in FUSCRAC3 is up
to 100 times less than the corresponding dose conversion factor in FUSCRAC2.
3.3.4 Latent Effects from Chronic Exposure
Once again, FUSCRAC3 computed doses which were larger than those
computed by FUSCRAC2 for all effects: 19 times higher for leukemia; 2 times
higher for lung cancer; 11 times higher for gastro-intestinal cancer; and 8 times
higher for cancer to the whole body. (Due to a printer malfunction, the dose
increases were not recorded for the thyroid and bone cancers.)
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This increase was expected as a result of the differences in the chronic
sections described in 3.3.1. It is believed that the reason for the smaller increase
in the number of lung cancers is because for P-32, P-33, W-181, W-185, and
W-187, the lung ingestion dose conversion factor is so much lower than it is for
all other organs considered. Therefore, the increase in the number of isotopes
evaluated by FUSCRAC3 does not largely affect the lung ingestion dose.
3.3.5 Conclusion
The fact that the comparison between the doses calculated by FUSCRAC3
and those calculated by FUSCRAC2 for a specific accident scenario yielded results
which were expected and which were easily explained by the inherent differences
between the two codes lends further credibility to the FUSCRAC3 computer code.
41
4.0 APPLICATIONS
4.1 Generation of Rem/Ci Data for 259 Isotopes
It was desirable to generate dose information on a Rem/Ci basis for each of
the 259 isotopes. One run was generated for each isotope using a 1 curie release
of that isotope and setting the inventories of all other isotopes to 0. Hence, the
doses calculated by the code yielded rem/Ci data for each isotope. The release
characteristics were chosen to simulate the study done by Fetter using his
FUSEDOSE code [9] for the Committee on Environmental Safety and Economic
Aspects of Magnetic Fusion Energy (ESECOM) [7, 8]. It was intended that the
rem/Ci data for each isotope would then be used for a comparison study between
the results predicted by FUSEDOSE and those predicted by FUSCRAC3 (see 4.2).
The release characteristics are specified in Table 4.1. They represent
pessimistic, worst-case assumptions. The fact that Fetter's code does not
distinguish between finite duration release times (i.e., there is no plume wandering
factor in FUSEDOSE) justifies the choice of a puff release (duration of release
equal to 3 minutes). The worst case accident scenario modeled by ESECOM was
a lithium fire lasting 10 hours, but setting the duration of release to 10 hours
would yield less conservative numbers, because FUSCRAC3 does consider plume
wandering, or spreading. Also, since a puff release is often chosen due to its
conservative aspects, the choice allows for a more universal application of the
results.
4.1.1 Spatial Mesh
The spatial mesh used is given in Table 4.2. Note that, for the ESECOM
study, the regions of interest were 2 and 8, where the midpoints of these intervals
were 1 km and 10 km, respectively. (Actually, these distances are often chosen,
so once again, the universality of the results is preserved.)
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Table 4.1. RELEASE CHARACTERISTICS
Worst case weather parameters:
Wind speed = 1 m/s
Pasquill stability class = F
Deposition velocity =
Inversion height = 250 m
0.001 M/s for H-3
0.0 m/s for noble gases
0.01 m/s for all other isotopes
Conservative release parameters
Waiting period after shutdown before release
Duration of release = 0.05 hours (3 minutes,
FUSCRAC3)
= 0.0 hours
minimum allowed by
Conservative site assumptions
Site boundary = 1 km
Ground level release
Initial plume dimensions:
Sigma-y = 100 m
Sigma-z = 50 m
Percentage of land for crop farming = 15%
Percentage of land for milk/meat production = 15%
No mitigative actions
No evacuation
No long-term population relocation
No interdiction of food
Groundshine shielding factor during plume passage = 0.7 (on a scale of 0.0
to 1.0, 1.0 meaning no shielding; 0.7 accounts for surface roughness of the
ground)
Groundshine shielding factor for chronic dose = 0.33 (accounts for the fact
that people will be outdoors for approximately 8 hours in a 24-hour day)
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This spatial mesh is not the most conservative choice, because the mesh
close to the site is not fine enough (i.e., spatial interval one covers 0.0 to 0.99
km). A more conservative spatial mesh would have used a finer mesh. This was
done by Steven Piet in some runs he did on his own. Table 4.3 shows his
spatial mesh. Thus, as a check, his spatial mesh was used (and all other inputs
were kept the same) for two isotopes for comparison. One Ci of Po-210 was
released, and two output files were created, one using the existing spatial mesh,
and one using Piet's spatial mesh. It was found that the doses in the two
output files showed differences of less than 1%. A similar comparison was made
for 1 Ci of H-3, and again, 'differences were less than 1%. It was thus concluded
that the spatial mesh presented in Table 4.2 is satisfactory.
4.2.2 Isotope Section
The limitation in the isotope section of the input file as discussed in 2.2.2
was taken into account. That is, when runs were executed for the 14 parent
isotopes listed in the "PARENT2" column of Table 2.1, those isotopes replaced
the corresponding isotope listed in the "PARENT1" column so that daughter
build-up effects for those 14 isotopes were included.
4.2.3 Data Output
As was discussed in Section 2.3.2, FUSCRAC3 had the capability of
generating an output file for each of the 259 isotopes containing information of
interest to this study, as follows:
1) acute effects from early exposure, reflecting the prompt dose to the
whole body, bone marrow, lung, and lower large intestine at 1 km,
where the prompt dose is defined as that dose delivered to a particular
organ from cloudshine during plume passage, seven days of groundshine,
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and the dose commitment over the organ-dependent acute time period
(as defined in Section 2.1.1) from inhalation during plume passage
(Recall from Section 2.1.1 that the critical time period is two days for
the whole body, seven days for the bone marrow and lower large
intestine, and one year for the lung.). Note also that the duration of
plume passage equals the duration of release, which is three minutes.
2) Latent effects from initial exposure to the whole body at 1 km; the
early dose, or dose from initial exposure, is that dose delivered from
cloudshine during plume passage, seven days of groundshine, plus the
50-year dose commitment from radioactivity inhaled during plume
passage; this differs from the prompt dose because the inhalation
commitment is over a longer period of time.
3) Latent effects from chronic exposure to the whole body at 1 kin, where
the chronic dose was broken down into the resuspension, ingestion, and
groundshine exposure pathways, and the time period of exposure was
50 years.
4) Latent effects from initial exposure to the whole body at 10 km (see
2) above).
5) Latent effects from chronic exposure to the whole body at 10 km (see
3) above).
6) Total number of cancers from both initial and chronic exposure, where
the body is treated as a sum of individual organs and calculations are
based on organ-specific dose factors and dose responses.
7) Total number of cancers from both initial and chronic exposure, where
the body is treated as a single organ and the whole body dose
conversion factors and dose response are used.
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8) Total whole body man rem, due to both initial plus chronic exposure
to the whole body-this is a population dose.
Numbers 6), 7) and 8) were chosen for reasons of universal applicability. They
were not actually used for the specific application discussed in 4.2, but such data
is often very useful in safety studies.
Cosmos files were created on the Cray machine, which ran 10 isotopes
sequentially, thus creating output files containing the necessary information for
each of the 10 isotopes per file. (A sample output file for Po-210 is found in
Appendix C.) These files were downloaded onto an IBM PC. The files
containing Fetter's FUSEDOSE results for the ESECOM study (see Section 4.2)
were also downloaded from the Cray, and the data in the files was manipulated
into a rem/Ci format. The information from the FUSCRAC3 runs and from the
FUSEDOSE runs was then combined in several steps involving much data file
manipulation, and the final result was the table listed in Appendix D.
The whole body chronic dose at 1 km and at 10 km listed in Appendix D
refers to the whole body dose due to both initial exposure and chronic exposure.
In other words, each of the three columns under the whole body chronic dose at
1 km reflects the addition of number 2) in the above description to the three
pathways in number 3). Similarly, the columns under the whole body chronic
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dose at 10 km reflect the addition of numbers 4) and 5). This definition of the
chronic dose as the total dose from initial exposure plus chronic exposure is
consistent with Fetter's definition of chronic dose (see Section 4.2). (Detailed
definitions of each of the columns is presented in Appendix D.)
In analyzing the data in Appendix D, it was noted that for some extremely
long-lived isotopes (half-lives greater than 1010 years), the prompt and 50-year
chronic doses were relatively low, but that the man-rem (calculated over a time
period from 0 to 80-plus years) was extremely high (105 to 10 9). This is
explained by the fact that in calculating the chronic dose, FUSCRAC3 truncates
at 50 years for groundshine, but does not for resuspension. Thus, it is possible
for an isotope to have a low (or zero) dose contribution from ingestion and
groundshine while having a high dose over the 50 to 80-plus year time period
from resuspension, thus yielding a large man-rem value. Examples of these
isotopes include: In-115 with zero contribution from groundshine and ingestion,
and an inhalation dose (due to resuspension) on the order of 10 ~4 rem/Ci over
the first 50 years, and an inhalation dose (due to resuspension) on the order to
10 6 for the 50-80+ year time period; and Sm-147, with zero groundshine and
ingestion, an inhalation dose on the order of 10 ~1 over the zero to 50-year time
period, and an inhalation dose on the order of 106 over the 50-80+ year time
period. These isotopes are usually not of interest to fusion, but if one were to
utilize the man-rem data for these extremely long-lived isotopes, one should have
a physical understanding of the large man-rem values.
Because the data in Appendix D was generated based on generic worst-case
assumptions and because the data is presented in rem/Ci format, it has many
possible applications. One simply multiplies the rem/Ci number for the time
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period (acute or latent) and distance (1 or 10 km) of interest by the number of
curies of the isotope being released, and one obtains a conservative dose estimate.
4.2 Applications to the ESECOM Study
4.2.1 Background
The senior committee on Environmental, Safety, and Economic Aspects for
Magnetic Fusion Energy (ESECOM) was organized in late 1985 in order to assess
fusion energy's prospects for presenting economic, environmental, and safety
characteristics that are attractive compared to those of existing energy sources.
Details of the committee's procedures and findings can be found in [7] and [8].
The application of FUSCRAC3's data focused on the accident analysis section of
the ESECOM study.
The ESECOM study reviewed seven fusion reference cases:
1) a deuterium-tritium tokamak reactor with a vanadium-alloy structure
and a liquid lithium coolant/breeder; denoted in tables as Case 1
and/or V-Li/TOK
2) a helium-cooled variant of the case 1 tokamak, with a reduced
activation ferritic steel (RAF) structure and a solid breeder Li 2O;
denoted in tables as case 2 and/or RAF-He/TOK
3) a high-power density reversed field pinch (RFP) machine with RAF
structure, a water-cooled copper-alloy first wall and limiter, and
self-cooled lithium-lead breeder; denoted in tables as case 3 and/or
RAF-PbLi/RFP
4) a high-power density RFP with a vanadium-lithium blanket; denoted
as case 4 and/or V-Li/RFP
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5) a low-activation tokamak with silicon carbide (SiC) structure, helium
coolant, and Li 20 breeder; denoted as case 5 and/or SiC-He/TOK
6) a pool-type tokamak with vanadium/alloy structure and molten salt
(FLIBE) coolant/breeder; denoted as case 6 and/or V-Flibe/TOK
7) an advanced fuel, deuterium-helium 3 fuel cycle with direct conversion
of microwave synchrotron radiation; water cooled tokamak; denoted as
case 7 (or case 8 by ESECOM) and/or V-D 3He/TOK
The fusion elements were categorized into five relative mobility classes based
on limited experimental data and on melting points and boiling points of the
elements and their oxides. The categories are presented in Table VII of [7],
which is reproduced here as Table 4.4.
Given the radioactive inventories (these were calculated by the committee)
and the mobility classes found in Table 4.4, the ESECOM committee then used
FUSEDOSE to calculate the off-site doses resulting form a release of 100% of the
radioactive inventory in each mobility category for each design. The inventories
were broken up into two categories for each isotope: the first wall inventory and
the inventory in the balance of the fusion core, referred to as BOFC. The BOFC
represented the blanket, the manifold/reflector, the shield, and the magnets (if
magnet activation was significant). All of the tritium in the blanket was counted
as if it were in the first wall.
Two different doses were calculated by FUSEDOSE:
1) The "critical" dose was defined to be the dose delivered in the first seven
days after exposure plus one-half the dose delivered in the eighth through
the thirtieth days. Three exposure pathways were considered: cloudshine
and groundshine during plume passage, and inhalation of radioactive material
51
Table 4.4. CATEGORIZATION OF RADIOACTIVE ISOTOPES
BY MOBILITY UNDER ACCIDENT CONDITIONS
CATEGORY DEFINITION ELEMENTS
I Elements gaseous or extremely volatile H, C*, N, Ar
under thermochemical conditions of normal
operation
II Elements somewhat volatile under thermo- Mg, P, Cl, Ca, Ag, Cd,
chemical conditions of normal operation Re, Hg
III Elements somewhat to highly volatile Na, Mn, As, Sr, Mo, Cu,
under conditions likely to be encountered Ni, Tc, T1, Po, Pb
in an accident
IV Elements somewhat volatile under conditions K, Co, V, Pd, In, Sb,
that may be encountered in severe accidents W, Te
V Elements resistant to volatilization even Be, Al, Si, Sc, Ti,
under extreme accident conditions Fe, Y, Zr, Nb, Sn, La,
Hf, Ta, Bi, Cr
*from activation of air
Temperature ranges are defined as follows:
normal operation
likely to be encountered in an accident
may be encountered in severe accidents
T < 800K
800K < T < 1200K
1200K < T < 1800K
It is assumed that the elements may come into contact with oxygen under
accident conditions, so formation of v6latile oxides has been taken into account.
Many of the categorizations are based on experimental data for V-15Cr-5Ti and
HT-9 ferritic steel. Relative mobilities in different alloys will not necessarily be
the same in all cases.
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during plume passage, where the duration of plume passage equalled the duration
of release, which was chosen to be 10 hours. The internal irradiation was
assumed to continue after the plume had passed; the external irradiation was
assumed to end with the end of the plume passage. A groundshine shielding
factor of 0.7 accounting for surface roughness was used, which is consistent with
FUSCRAC3. Furthermore, because FUSEDOSE cannot account for plume
spreading (see Section 4.1), a duration of release equal to 10 hours caused no loss
of conservation due to plume wandering.
2) The "chronic" dose was defined as the dose from ground contamination and
resuspension over a 50-year exposure period plus the 50-year dose
commitment resulting from initial exposure. A groundshine shielding factor
was implemented to account for surface roughness and the individual's being
indoors part of the time. This number was not documented, but a
conversation with Fetter revealed that the choice of shielding factor ~ 0.33
was probably made (consistent with FUSCRAC3). Fetter's "chronic" dose
does not account for the ingestion pathway.
The committee then calculated what it called "threshold-dose release
fractions", or TDRFs, for each design. A TDRF is defined as that fraction of
the inventory (FIRST WALL or BOFC) that, if released under pessimistic
conditions, would lead to a dose exceeding an established threshold. TDRFs were
calculated for two different thresholds:
1) The "critical dose threshold" was defined as a "critical" whole body
dose commitment of 200 rem delivered by passage of the plume to an
individual located in the open at a distance of 1 km from the release.
The choice of 200 rem corresponds to the smallest whole-body dose
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with a perceptible chance of causing an early fatality in a sensitive
individual.
2) The "chronic" dose threshold was defined as a 50-year whole-body
dose of 25 rem from ground contamination and resuspension at a
distance of 10 kilometers from the release.
The higher the TDRF, the better; a TDRF exceeding unity would mean
that release of 100% of the first wall/BOFC inventory would be insufficient to
produce the threshold dose. The results of the ESECOM accident analysis dose
calculations are reproduced in Tables 4.5, 4.6, and 4.7 from documents [7] and [8].
It was determined that it would be instructive to re-do the dose calculations
performed by ESECOM using FUSCRAC3. There are some major differences in
the models used by FUSEDOSE and FUSCRAC3, and two of these differences
enhance the desirability of re-examining the results: 1) FUSEDOSE contains the
"old" dose conversion factors and FUSCRAC3 contains the most up-to-date
numbers; hence, FUSCRAC3 should produce results reflecting the more accurate
dose conversion factors; and 2) FUSEDOSE does not account for the ingestion
exposure pathway; therefore, an examination of the impact of ingestion on the
overall chronic dose should be made using FUSCRAC3.
The information in Appendix D was used to calculate the doses from a
100% release of the inventory of every isotope in every mobility category in every
design. No assumptions were made about the insignificance of certain isotopes;
every isotope was examined. The format of the ESECOM study described above
was followed, and the results are presented in Tables 4.8 and 4.9. The organ
chosen for both acute and latent effects was the whole body, since this was what
was chosen by ESECOM. The inventories for all isotopes except H-3 were
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TABLE 4.5: DOSE-THRESHOLD RELEASE FRACTIONS BY COMPONENT ANO MOBILITY
CATEGORY (ESECOM RESULTS)
Release Fraction That Would Produce
Inentories 200-rem Critical Dose 25-rem 50-yr Ground
Case and ONCi) from Plume at I km Dose at 10 km
Mobility
Categories First Wal I BOFC First Wall BOFC First Wall BOFC
Case 1: V-Li/TOK
$ . 0.077 52 7100 Is 260
1-110 6.0 6.3 5.0 0.78 0.82
3-333 10 560 5.1 0.027 0.55 0.00011
lIV 95 670 3.7 0.027 0.021 0.00010
I-V 540 2400 0.036 0.015 0.0016 0.00009
Case 2: RAF-He/TOK
1.7 0.040 160 2 x 10' 56 4400
1-l7.1 16 5.7 2.3 2.3 0.6
I-Ill 390 450 0.036 0.032 0.00011 0.00011
lIV 510 670 0.035 0.028 0.00011 0.00010
3-V 1200 1300 0.033 0.027 0.00011 0.00010
Case 3: RAF-PbLi/RFP
1 0.531 0.032 510 4 x 103 1SO 2200
1-11 21 20 1.9 0.63 0.70 0.076
1-111 120 430 0.031 0.011 0.000%6 0.00019
-Ky 220 3300 I 0.028 0.011 0.00013 0.00017
3-V 2500 1600 0.028 0.010 0.00013 0.00010
Case 4: V-Li/RFP
1 5.0 0.07 51 2x 10' IS 350
1-11 6.5 6.3 17 4 2.4 0.17
1-111 6.5 940 14 0.012 1.9 0.00010
I-V 38 1100 8.1 0.011 0.031 0.00008
1-V I80 4600 0.099 0.0084 0.0047 0.00008
Case 5: SiC-Ne/TOK
T 1.7 2.1 160 220 56 77
1-11 8.2 14 86 17 55 12
1-111 8.3 Is 41 3.1 8.4 0.095
I.IV 8.0 230 41 0.13 2.9 0.016
I-V Soo 1500 21 0.13 2.9 0.016
Case 6: V-Flibe/TOK
1 0.17 0.01 1600 1 x 30 60 57W0
1-1110.% 41 38 4.7 4.8
1-1 . .2 32 22 3.0 0.32
I-IV 17 16 19 14 0.90 0.060
-V Ito 220 0 20 0.21 0.0096 0.008
Case 8: V-'HIe/TOK
I 0.0 0.006 500 8 x 10 I80 2 x 10'
1-13 0.81 0.038 100 960 13 120
1-111 0.82 0.66 29 20 9.5 0.053
I-IV 6.8 1.2 26 20 6.3 0.052
I-V 62 4.7 0.538 4.4 0.027 0.043
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TABLE 4,6: CRITICAL-DOSE TDRFs AND DOMINANT ISOTOPES (ESECOM RESULTS)*
Rest of inner
First wall blanket Manifold/reflector Shield
Case and Threshold Threshold Threshold Threshold
mobility release Dominant release Dominant release Dominant release Dominant
category fraction isotopes fraction isotopes fraction isotopes fraction isotopes
Case 1: V-Li/TOK
I 50 H3
I-11 6 Ca45,Ca47
I-11 5 Ca45,Na24
I-IV 4 Ca45,Na24
I-V 0.04 Sc48
Case 2: RAF-He/TOK
I 200 H3
I-1I 6 Re186,Re188
I-Il 0.04 Mn56,Mn54
I-IV 0.04 Mn56,Mn54
I-V 0.03 Mn56,Mn54
Case 3: RAF-PbLi/RFP
1 500 H3
I-1I 2 Re188,Re186
I-11 0.03 Cu64,Mn56
I-IV 0.03 Cu64,Mn56
I-V 0.03 Cu64,Mn56
Case 4: V-Li/RFP
I 50 H3
I-Il 20 Ca45.Ca47
I-11 10 Ca45,Na24
I-IV 8 Ca45,Na24
I-V 0.1 Sc48
Case 5: SiC-He/TOK
I 200 H3
I-U 90 Mg27,H3
I-II 40 Na24,Mg27
I-IV 40 Na24,Mg27
I-V 20 A129,Na24
Case 6: V-FLiBe/TOK
I 2000 H3
I-I1 40 Ca45,Ca47
I-Il 30 Ca45.Na24
I-IV 20 Ca45,Na24
I-V 0.2 Sc48
Case 8: DHe /TOK
1 500 H3
I-I 100 Ca45,H3
I-11 80 Ca45,Na24
I-IV 60 Ca45,Na24
I-V 0.6 Sc48
2e4 H3
8 Ca45,Ca47
6 Ca45,Na24
5 Ca45,Na24
0.04 Sc48
2e4 H3
3 Re186,Re188
0.03 Mn56,Mn54
0.03 Mn56,Mn54
0.03 Mn56,Mn54
4e3 Ar41
0.6 P32,Re188
0.01 Po2lO,Mn56
0.01 Po2lO.Mn56
0.01 Po210,Mn56
6e4 H3,N13
10 Ca45
7 Ca45,Na24
6 Ca45,Na24
0.04 Sc48
le4 H3
40 P32,Mg27
20 P32,Mn54
10 P32,Mn54
9 A129,P32
le5 H3
40 Ca45,P32
20 Ca45,Na24
8 Ca45,Na24
0.2 Sc48
le6 H3
1e3 Ca45
800 Ca45,Na24
700 Ca45,Na24
6 Sc48
1e4 H3
10 P32,Ca45
0.03 Mn56,Mn54
0.03 Mn56,Mn54
0.02 Mn56,Mn54
3e6 H3
7 ReI88,Re186
0.9 Mn56,Mn54
0.3 W187,Mn56
0.3 W187,Mn56
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
leg C14
9000 Mg27
8000 Mg27
1000 Co6O,Mg27
500 Si31,Co60
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
NA NA
3e5 H3
400 P32
0.6 Mn56
0.6 Mn56
0.4 Mn56,Fe59
3e4 H3
400 P32
0.7 Mn56,Mn54
0.5 Mn56,Mn54
0.4 Mn56,Fe59
5e6 H3
400 P32
0.7 Mn56
0.7 Mn56
0.6 Mn56,Fe59
2e4 H3,N13
7 P32
0.01 Mn56,Cu64
0.01 Mn56,Cu64
0.01 Mn56,Cu64
200 H3
30 Re188.Re186
4 Na24.Re188
0.1 W187
D.1 W187
2e8 H3
3e5 P32,Ca45
500 Mn56,Mn54
100 Co6O,Mn56
100 Co6O,Mn56
3e6 H3
9e3 H3,P32
20 Mn54,Mn56
20 Mn54,Mn56
20 Mn54,Mn56
*The figures shown are the fraction (or multiple) of the iriventory in the stated component and mobility
category that would produce a critical whole-body dose of 200 rem at 1 km from the release under pessimistic
assumptions. NA means not applicable.
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TABLE 4 7: CHRONIC-DOSE TORFs ANO DOMINANT ISOTOPES (ESECOM RESULTS)a
Rest of inner
First wall blanket Manifold/reflector Shield
Case and Threshold Threshold Threshold Threshold
mobility release Dominant release Dominant release Dominant release Dominant
category fraction isotopes fraction isotopes fraction isotopes fraction isotopes
Case 1: V-Li/TOK
15 H3
0.8 Ca45,Ca47
0.6 Ca45,Mn54
0.02 Cr51
0.002 Sc46,Sc48
RAF-He/TOK
50 H3
2 Re186,
Re 188
le-4 Mn54
le-4 Mn54
le-4 Mn54
RAF-PbLi/RFP
200 H3
0.7 Rei188,
Re186
I-IV
'-III
I-v
Case 2:
I
I-II
-III
I-IV
I-v
Case 3:
I-II
'-III
'-IV
I-v
Case 4:
I
I-II
I-III
I-IV
I-v
Case 5:
I
I-IV'INI
I-V
Case 8:
I-Il
'-III
'-IV
I-V
Case 8
300
1
0.6
0.03
0.002
H3
Ca45.Ca47
Ca45,Mn54
Cr51
Sc46,Sc48
5e3 H3
1 Re186,
Re188
le-4 Mn54
le-4 Mn54
le-4 Mn54
6e3 H3
0.08 Ag108m,
Agil0m
2e-4 Mn54
le-4 Mn54,Co6O
9e-5 Mn54,Bi207
le3
5
3
0.1
0.008
4e3
30
0.1
0.06
0.06
6e3
5
0.4
0.07
0.009
Ar52
Ca45
Ca45,Mn54
Cr51
Sc46,Sc48
H3,Ar41
P32,Ca47
Mn54,Na22
Mn54,Co60
Mn54,Co6O
H3,C14
Ca45,Ca47
Mn54
Ca51.Co60
Sc46,Sc48
4e3
6
le-4
le-4
le-4
H3
P32,
Mn54
Mn54
Mn54
1e6 H3
2 Ag110m,
Re186
0.007 Mn54
0.003 Co60,Mn54
0.003 Co60,Mn54
NA NA
NA NA
NA NA
NA NA
NA NA
NA
NA
NA
NA
NA
3e6
4e4
400
0.6
0.6
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
C14
P32
Mn54
Co60
Co60
NA
NA
NA
NA
NA
3e4
300
0.01
0.004
0.003
4e4
400
0.007
0.005
0.004
H3
P32,Ca45
Mn54
Co6OMn54
Co60,Mn54
C14
P32
Mn54
Mn54,Co6O
Mn54,Co6O
1e6 H3
300 P32
0.02 Mn54
0.02 Mn54
9e-3 Mn54,Fe59
Ie3
0.2
le-4
8e-5
8e-5
80
20
1.5
0.02
0.02
6e7
8e3
4
0.1
0.1
Ar42
Ag108m
Mn54
Mn54,Co6O
Mn54,Cu6O
H3
Re188,Re186
Na24,Re188
W187,W 181
W187,W181
C14,H3
P32
Mn54
Co58,Mn54
Co48,Mn54
I 200 H3 3e4 H3,Ar42 NA NA 3e3 H3,C14
I-lI 15 Ca45 100 Ca45,Ca47 NA NA 2e3 H3,P32
-III 10 - Ca45,Mn54 90 Ca45.Mn54 NA NA 0.05 Mn54
1-1V 0.3 Cr51 4 Cr5l,Ca45 NA NA 0.05 Mn54
I-V 0.03 SC46,Sc48 0.2 Sc46,Sc48 NA . NA 0.05 Mn54
OThe figures are the fraction (or multiple) of the inventory in the stated
component and mobility category that would produce a chronic whole-body doce of
25 rem at 10 km from the release under pessimistic assumptions. NA means not applicable.
9e-4 Mn54
le-4 Co60,Mn54
le-4 Co6O,Mn54
V-Li/RFP
20 H3
2 Ca45,Ca47
2 Ca45,Mn54
0.06 Cr51
0.005 Sc46,Sc48
SiC-He/TOK
50 H3
50 H3
8 Mn54,Na24
3 CoO,Mn54
3 Co60,Mn54
V-FLiBe/TOK
500 H3
5 Ca45,Ca47
3 Ca45,Na24
0.1 Cr51
0.01 Sc46.Sc48
DHe /TOK:
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Table 4.8. DOSE-THRESHOLD RELEASE FRACTIONS BY COMPONENT AND MOBILITY CLASS
Case and Release Fraction that Would Produce:
Inventories
Mobility (MCi) 200 rem Critical Dose 25-rem 50-yr Chronic 25-rem 50-yr Chronic
from Plume at 1 km Dose (ground, resusp., Dose (ground + resusp
Categories ingestion) only; no ingestion)
First Wall BOFC First Wall BOFC F First WalI BOFC
CASE 1: V-Li/TOK
I 3 0.068 345 1.8e+04 0.46 21.7 17.9 4.07e+03
I-I1 10 6.0 7.1 9.1 0.0060 0.0058 1.18 1.25
I-i1 10.5 576 3.0 0.0042 0.0060 0.0002 0.913 0.00044
I-V 95 670 1.01 0.0041 0.0057 0.00018 0.463 0.00042
I-V 544 2490 0.0039 0.002 0.0018 0.00011 0.0034 0.00034
CASE 2: RAF-He/TOK
1 1.7 0.051 1021 3700 1.36 27.2 53.2 3571
1-I 7.2 16 4.08 1.54 0.10 0.002 3.76 1.53
I-I1 392 446 0.0047 0.0044 0.0023 0.00021 0.00046 0.00044
I-IV 460 620 0.0046 O.009 0.00023 0.00019 0.00046 0.00041
I-V 1240 1260 0.0043 0.0036 0.00013 0.00013 0.00044 0.00040
CASE 3: RAF-PbLi/RFP
1 0.51 0.40 3390 low5 4.55 39.1 179 1121
1-1 21.5 24.0 1.18 0.435 0.096 0.0043 1.22 0.119
1-111 1800 1290 0.008 0.0036 0.0014 9.3906 0.000 0.00068
I-IV 1880 1480 0.0061 0.0031 0.00032 9.39-46 0.00053 0.00042
I-V 2490 1860 0.0059 0.0027 0.00029 8.98-06 0.00052 0.00029
CASE 4: V/Li/RFP
1 5.0 0.02 339 .8e+.04 0.435 119 18.0 1.le+04
1-11 6.5 3.7 18.2 11.1 0.0=0 0.0147 3.47 0.689
1-111 6.6 941 8.00 0.0034 0.0208 0.00019 2.84 0.00040
I-IV 38 1050 0.36M 0.0032 0.0179 0.00017 0.179 0.00034
I-V 182 4540 0.01 0.0018 0.00" 0.00013 0.0096 0.00031
CASE 5: SiC-He/TOK
1 1.8 2 100 833 1.32 1.32 31.0 53.2
1-1 8.4 14 48.8 12.5 1.32 0.25 51.0 16.0
1-411 8.4 15 12.5 0.714 1.14 0.044 12.5 0.309
1-IV 8.4 230 12.5 0.0218 1.04 0.004 7.58 0.025
I-V 797 1500 4.17 0.0215 1.0 0.0089 T.58 0.025
CASE 6: V-FLIDE/TOK
1 0.18 0.002 8897 2.5+05 13.16 78.12 510 1.67e+05
1-11 1.00 1.1 39.0 4.1 0.036 0.035 7.14 7.35
1-111 1.13 1.1 16.67 7.T8 '.036 0.033 5.43 1.19
[-IV 5 164 3.85 2.30 033.02 2.06 0.25[-V 114 223 0.022 O.M2 10.011 0.0097 0.0192 0.0192
CASE 7: V-D3 He/TOK
1-U
I-IV
I-V
0.5 0.036 3448 4.9e+04 4.55 64.1 178.6 2500
0.81 0.073 133 1429 0.10 0.86 22.1 192.3
0.82 0.70 54 2.25 0.10 0.093 17.2 0.23
6.8 1.2 2.00 2.04 0.086 0.089 0.93 0.23
62 4.77 0.061 0.47 0.029 0.061 0.056 0.16
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Table 4.9. DOMINANT ISOTOPES FOR CRITICAL AND CHRONIC DOSES
Case and Dominant Isotopes (Q -10% of the Dose)
Mobility Critical (2-day Whole Chronic - 50 yrs; round. Chronic - 50 yrs; ground and
Body Dose) resuap., and ingestion resum.; iw ingestionCategories
First Wall BOFC First Wall BOFC First Wall BOFC
CASE 1 lsoto Isotope Isotope ISoto IIto(Ci;%o ZCiof (Ci; % of (10; % of (Ci;. T Olo Of (Ci; Z of
total dose) total dose) total dose) total dose) mota] dose) total dose)
I H-3 (0.57; 98%) N-13 (7.2e-03; 65%) H-3 (54; 100%) C-14 (0.94; 82%) H-3 (1.4; 100%) H-3 (5.30-03; 89%)
H-3 (2.2e-03: 20%) H-3 (0.21; 18%)
Ar-41 (1.80-03: 16%)
1-11 Ca-47 (23; 82%) Ca47 (16; 73%) Ca-45 (4.le+03; Ca-4U (4.0e+03; Ca-4 (17; 81%) Ca-4 (17; 85%)
Ca-45 (3.4; 12%) Ca-45 (3.3; 15%) 100%) 93%) Ca-47 (2.7; 13%)
P-32 (2.5; 11%)
1-Ill Na-24 (35; 53%) Mn-54 (4.0e+04; Ca-45 (4.le+03; Mn-S4 (1.2e+05; C" (T17; 63% Mn-S4 (5.6e+04;
Ca-47 (23; 35%) 83%) 100%) 92%) N6-24 (3.2; 12) 99%)
Mn-56 (8.3e+03; Mna-4 (3.0; 11
17%) Ca-47 ( .7; 10%)
[-IV V-48 (95; 50%) Mn-54 (4.0e+04; Ca-4 (4.le+03; Mn-S4 (1.2e+05; V-4 (18; 34%) Mn-"4 (5.6e+04;
82%) 93%) 86%)
Na-24 (35; 19%) Mn-56 (8.3e+03; Ca-" (17; 32%) 93%)
V-52 (24: 13%) 17%) V-49 (5.4; 10%)
Ca-47 (23; 12%)
I-V Sc-48 (4.6&+04; Sc-48 (4. le+04; Sc-4 (5.9s+03; Mn-SO (1.2e+05; Sc-48 (4.6e+03; Mn-54 (5.6e+04;
89%) 41%) 42%) 55%) 63%) 80%)Mn4 (4.0@+04; Ca-4 (4.1*+03; Fe-Ga (6.00+04; Sc-46 (2.20+03;
40%) 29%) 27%) 30%)
Sc-46 (2.7e+03; 19%)
CASE 2
1 H-3 (0.2; 100%) Ar-41 (0.05; 100%) H-3 (18; 100%) C-14 (0.91; 99%) H-3 (0.47; 100%) Ar-41 (6.50-03; 93%
1-41 Re-186 (37; 76%) Re-186 (63; 49%) Re-INl (8; 39%) P-32 (170; 39%) R0186 (4.4; 76%) Re-186 (7.5; 47%)
Re-1I8 (11; 22%) Re-Ill (63; 49%) Ca-" (82; 36%) Re-Ill (150; 34%) Re-Ill (0.93; 14 Re-Ill (5.3; 33%L
P32 (50; 22%) Ca"5 (77; 18% Ag-110m (1.8; 11%)
Re-Ill (40; 9%
I-I1 Ma-S4 (3.8e+04; Ma-S (4.00+04; M-4 (1.10+05; Ma-64 (1.2"+M0; Ma-SO (5.4+04; M-54 (5.70+04;
88%) 87%) 100% 100%) 99%) 100%)
Mn-66 (5300; 12%) Ma-U (ON; 13%)
I-IV Ma-54 (3.80+01; Me-64 (4.0@+04; Ma-64 (1.10+05. Mm-SO (1.20+05: Ma-4 (5.40+04; Mn-4 (5.70+04;
86%) 78%) 100% 92%) 96%) 93%)
Mn-56 (5300; 12%) Ma-il (Of; 12%)
I-V Mn-SO (3.80+04; Ma44 (4.00+04; Ma-64 (1.10+05; Mn-S4 (1.20+05; Mn-4 (5.40+04; Mn-S4 (5.7e+04;
81%) 73%) 55% 60%) 95%) 91%)
Mn-56 (5300; 11%) Ma-66 (GM,: 11%) Fe-5G (8.1.+04; Fe-55 (6.5e+04;
41%) 33%)
CASE 3
H-3 (0.50; 100%) Ar-4 (0.18; 95%) H-3 (5.5; 100%)
Re-188 (110; 65%) Hf-= (300; 65%) Re186 130; 52%)
Re-I6 (52; 31%) Re-Il (57; 12%) Re-il (70; 27%)
P-3 (44; 10%) P-32 (23; 9%)
I-l1l Cu-S4 (l.Se+04;
72%)
Mn-54 (4800; 19%)
Mn-S4 (2.20+04;
40%)
Pb-203 (1.29+04;
22%)
Mn-56 8800: 16%
TI-202 6900: 13%
Mn-O (1.4e+04;
78%)
Cu-44 (2300; 13%)
C-14 (0.62; 97%) H-3 (0.14; 100%) Ar-41 (0.022; 100%)
P-32 (5.10+03; 88%)R* - 3; 4T% Hg-203 (110; 5
Re-I 18(.2; 31%) A-108m (47; 22
Ag-I0m (4.3; 22%) Ag-ilm (22; 11%)
P-32 (22; 11%)
Po-210 (2.6e+06; Mm-4 (6.70+03; Mn-64 (3.00+04;
96%) 81%) 81%)
Cu-4 (1.50+03; Po-210 (3.8e+03;
18%) 10%)
I-i1
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Case and Dominant Isotopes (? -10% of the Dose)
Mobility Critical (2-day Whole Chronic - 50 yrs: round. Chronic - 50 yrs: ground and
Body Dose) reSuip., and ingestion resump.; 1w ingestion
First Wall BOFC First Wall BOFC First Wall BOFC
CASE 3
[-IV Cu-64 (1.8e+04; Mn-54 (2.2e+04: Co-60 (6.le+04; Po-210 (2.6e+06; Co-0 (3.9e+04; Mn-54 (3.0e+04;
55%) 34%) 77%) 96%) 83%) 51%)
Co-60 (7100: 22%) Pb-203 (1.2e+04; Mn-54 (1.4e+04; Mn-54 (6.7e+03; Co-60 (2.1e+04;
Mn-54 (4800: 15%) 19%) 18%) 14%) 36%)
Mn-56 (8800; 14%)
TI-202 (6900; 11%)
I-V Cu-64 (1.8e+04: Mn-54 (2.2e+04; Co-60 (6.le+04; Po-210 (2.6e+06; Co-60 (3.9e+04; Mn-4 (3.0e+04;
53%) 30%) 76%) 93%) 81%) 35%)
Co-60 (7100; 21%) Pb-203 (1.2e+04; Mn-54 (1.4e+04; Mn-54 (6700; 14%) Bi-207 (2.2e+04;
Mn-54 (4800; 14%) 16%) 16%) 26%)
Mn-56 8800; 12%) Co-0 (2. 1e+04;
TI-202 6900; 9%) 25%)
CASE 4
I H-3 (0.58; 98%) N-13 (9.1e-03; 83%) H-3 (5.5e+01; C-14 (0.12; 57%) H-3 (1.4; 100%) H-3 (2.2e-03;
100%) 57%) 96%)
H-3 (0.086; 41%)
1-11 Ca-47 (8.9: 90%) Ca-47 (6.1; 34%) Ca-45 (1100; 92%) Ca-45 (1.2e+03; Ca-45 (4.8; 67%) Ag-108m (27: 75%)
P-32 (43; 24%) 71%) H4-3 (1.4; 19%) Ca-45 (5.1; 14%)
Re-188 (2.7; 15%) P-32 (500; 29%) Ca-47 (1.0; 14%)
I-Il1 Na-24 (13; 52%) Mn-54 (4.3e+04; Ca-45 (1100; 92%) Mn-54 (1.3ee+05; Ca-45 (4.8; 55%) Mn-4 (6.le+04;
74%)
Ca-47 (8.9; 36%) Mn-56 (1.5e+04; -100%) H-3 (1.4; 16%) 98%)
26%) Na-24 1.1; 13%)
Ca47 1.0;11%)
I-IV Cr-51 (520; 95%) Mn-54 (4.3e+04; Ca-45 (1100: 79%) Mn-64 (I.3e+05; Cr-SI (130; 93%) Mn-54 (6.le+04;
69%) 87%) 84%)
Mn-56 (1.Se+04; Cr-51 (230; 16%) Co-0 (1.5e+04; 10%) Co-0 (9800; 13%)
24%)
-V Sc-48 (1.7e+04; Mn-54 (4.3e+04; Sc-48 (2100; 47%) Mn44 (1.3e+05; Sc-48 (1700; 65%) Mn-54 (6.le+04;
85%) 39%) Ca-45 (1100; 24%) 65% Sc-46 (750; 29%) 75%)
Cu-44 (2.le+04; Sc-46 (900; 20%) Fe-55 (3.2e+04; Co-GO (9800; 12%)
19%) 16%)
Sc48 (1.7e+04;
15%)
Mn-66 (1.30+04;
14%)
Fe4O (1.10+04;
10%)
CASE 5
1 H-3 (0.2; 100%)
1-I1 Mg-27 (3.9; 95%)
I-Ill Na-24 (12: 75%)
Mg-27 (3.9: 24%)
I-IV Na-24 (12; 75%)
Mg-27 (3.9; 24%)
I-V Al-29 (18; 38%)
Al-28 (14; 29%
Na-24 (12; 25%)
H-3 (0.19: 79%) H-3 (19; 100%)
Ar-41 (0.048; 20%)
Re-188 (6.4; 40%) H4-3 (19; 100%)
Mg-27 (6.2; 39%)
RO-186 (2.0; 13%)
Na-24 (220; 79%) H-3 (19; 86%)
Mn-54 (31; 12%)
W-187 (8800; 96%) H-3 (19; 79%)
W-187 (8800; 95%) H-3 (19; 76%)
H-3 (18; 95%) H-3 (0.49; 100%)
P-32 (74: 74%) H4-3 (0.49; 100%)
H-3 (18; 18%)
Na-22 (350; 61%)
Mo-54 (91; 16%)
P- (74; 13%)
W-187 (1200; 44%)
W-185 710; 26%)
Na-22 (380; 13%)
W-187 (1200; 43%)
W-185 (710; 25%)
Na-22 (350; 13%)
Na-24 (1.1; 55%)
H4-3 (0.49; 25%)
Mn-54 (0.37; 19%)
Co-0 1.2; 36%)
Na-24 1.1; 33%)
H-3 (0.49 15%)
Mn-54 (0.37; 11%)
Co-G (1.2:36%)
Na-24 (1.1; 33%)
H-3 (0.49; 15%)
Mn-54 (0.37; 11%)
H-3 (0.47; 100%)
Re-188 (0.53; 34%)
H4-3 (0.47; 30%)
P-32 (0.32; 21%)
Re-186 (0.24; 15%)
Mn-44 (44; 54%)
Na-24 (20: 25%)
Na-22 (15; 19%)
W-187 (830; 83%)
W-187 (830; 83%)
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Case and Dominant Isotopes (Q -10% of the Dose)
Mobility Critical (2-day Whole Chronic - 50 yrs; ;round, Chronic - 50 yrs; ground andBody Dose) resusp., and ingestion resusp.; no ingestion
First Wall BOFC First Wall BOFC First Wall BOFC
CASE 6
H-3 (0.02; 87%) N-13 (7.le-04; 88%) H-3 (1.9; 100%) C-14 (0.32; 100%) H-3 (4.9e-02: 100%) C-14 (1.5e-04; 100%
[-[I Ca-47 (4.5; 88%) Ca-47 (3.0; 81%) Ca-45 (700; 100%) Ca-45 (710; 99%) Ca-45 2.9; 83%) Ca-45 (3.0: 88%)
Ca-45 (0.58; 11%) Ca-45 (0.59; 16%) Ca-47 (0.52; 15%) Ca-47 (0.35; 10%)
I-II Na-24 (5.9: 49%) Mn-54 (12; 46% Ca-45 (700; 100%) Ca-45 (710; 93%) Ca-45 (2.9; 63%) Mn-54 (17; 81%)
Ca-47 (4.5; 38%) Na-24 (5.9; 23% Mn-54 (0.62; 13%) Ca-45 (3.0; 14%)
Ca-47 (3.0; 12% Na-24 (0.53; 12%)
Ca-47 (0.52; 11%)
(-V V-48 (33; 63%) Co-58 (24; 28%) Ca-45 (700; 92%) C45 (710; 80%) V-48 (6.2; 52%) Co-60 (68; 68%
V-52 (6.6; 13%) V-52 (22; 25%) Co-EU (100; 11%) Ca-46 (2.9; 24%) Mn-54 (17; 17%)
Na-24 (5.9; 11%) Co-60 (12; 14%) V-49 (1.3; 11%) Co-SI (12; 12%)
Mn-54 (12; 14%)
I-V Sc-48 (8100; 88%) Sc-48 (7700; 87%) Sc-48 (1000; 42%) Sc-48 (980; 38%) Sc-48 (810; 62%) Sc-48 (770; 59%)
Ca-45 (700; 29%) Ca5 (710; 27% Sc-46 (370; 29%) Sc-46 (400; 31%)
Sc-46 (440; 18%) Sc-46 (480; 1
CASE 7
I H-3 (0.058; 100%)
I-Il Ca-47 (1.2; 80%)
Ca-45 (0.2; 13%)
1-111 Na-24 (2.0; 54%)
Ca-47 (1.2; 32%)
[-IV Cr-51 (97; 97%)
1-V Sc-48 (2900; 88%)
H-3 (4.10-43; 100%) H-3 (5.5; 100%)
Ca-47 (0.11; 79%) C45 (240; 96%)
Ca-45 (0.023; 16%)
Mn-54 (81; 91%) Ca-45 (240; 96%)
Mn-54 (81: 83%)
Sc-48 (300; 70%)
Mn-54 (81; 19%)
Ca-45 (240; 83%)
Cr-S1 (42; 15%)
Sc-48 (360; 42%)
Ca-45 (240; 28%)
Sc-46 (150; 18%)
H-3 (0.39; 100%)
Ca-45 (28; 97%)
Mn-54 (240; 89%)
Ca-45 (28; 10%)
Mn-54 (240; 86%)
Ca-45 (28; 10%)
Mn-54 (240; 59%)
Fe-M5 (65: 16%)
Sc-48 (38; 9%)
H-3 (0.14; 100%)
Ca"4 (0.99: 88%)
H-3 (0.14; 12%)
-Ca-45 (0.99; 62%)
Na-24 (0.18; 11%)
H-3 (0.01; 100%)
Ca-45 (0.12; 92%)
Mn-54 (110; 100%)
Cr-51 (25; 93%) Mn-54 (110; 100%)
Sc-48 (290; 64%)
Sc-46 (120; 27%)
Mn-54 (110: 69%)
Sc-48 (30; 19%)
Sc-46 (16; 10%)
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obtained directly from Fetter's case files stored on the Cray. The tritium
inventories were obtained directly from Table 6.2 in [8], because the ESECOM
study accounted for tritium removal systems, which would decrease the amount of
tritium found in the blanket. As with the ESECOM study, all of the tritium in
the blanket was treated as if it were in the first wall. The only other tritium
was located in the shield (and was assumed to remain in the shield). (See Table
6.2 in [8] for tritium inventories used.) Furthermore, some isotopes had large
inventories but negligible contribution to the total dose (N-16 and V-52, for
example). It was noticed that Fetter did not include the inventories from these
isotopes in his data table (Table 4.5), since such an inclusion would be
misleading. The same tactic was employed in the generation of Tables 4.8 and
4.9.
4.2.2 Differences Between FUSEDOSE and FUSCRAC3
Before any comparisons are made, it is essential that one be aware of the
differences between the two computer codes (FUSEDOSE and FUSCRAC3); some
of these differences are very significant and have large effects on the data:
1) Prompt or critical dose: (The word "prompt" is associated with
FUSCRAC3, and the word "critical" is associated with FUSEDOSE; there
are differences in the meanings as described below, but essentially they both
refer to doses incurred during initial plume passage.)
i) Inhalation exposure: As described in Section 2.1.1, the prompt dose
due to inhalation during plume passage is calculated by FUSCRAC3 by
integrating over an organ-dependent time period. For the whole body,
this time period is two days. FUSEDOSE, on the other hand,
considers the "critical" dose to be that dose due to inhalation during
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plume passage delivered in the first seven days after the initial exposure, plus
one-half the dose delivered in the next 23 days. The duration of plume passage
used by FUSCRAC3 was three minutes, while that used by FUSEDOSE was 10
hours. However, the total amount of radioactivity released in both cases was the
same. Thus, if an inhalation-dominated isotope has a biological half-life
significantly greater than 10 hours (tritium, for example) the biological decay-
pathway can be ignored, and the amount of the isotope inhaled can be assumed
to be the same in both cases. Thus, the difference in the durations of plume
passage should not cause significant differences in the prompt doses calculated by
the two codes for inhalation-dominated isotopes. However, the vast difference in
the definitions of critical time period (2 days vs. 7 days plus one-half the next 23
days) should result in significant differences. Thus, for inhalation-dominated
isotopes such as H-3, P-32, Ca-45, and Fe-55, one would expect the "critical"
dose calculated by FUSEDOSE to be higher than the "prompt" dose calculated by
FUSCRAC3. This conclusion is indeed supported by the data in the table in
Appendix D. The effect of this difference is particularly pronounced in the
TDRFs for mobility category I, which is tritium dominated. The TDRFs
calculated by FUSCRAC3 for this category exceed those calculated by
FUSEDOSE by factors of 6 to 7 for each design.
ii) Groundshine exposure: As discussed in Section 2.4.3, the "prompt"
groundshine exposure time is decided by the user. The conservative
choice is seven days, and for reasons of consistency and conservatism,
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seven days was indeed chosen. However, the FUSEDOSE "critical"
groundshine dose was calculated based on an irradiation time
corresponding to the duration of release, which was chosen to be 10
hours. This large difference in assumed exposure time leads one to
conclude that for groundshine-dominated isotopes such as Na-24,
Sc-48, Mn-54, Fe-59, Co-60, W-187, Tl-202, and Pb-203,
FUSCRAC3's "prompt" dose should be significantly greater than the
"critical" dose calculated by FUSEDOSE. This conclusion is also
supported by the table in Appendix D. For every design, this effect
was quite significant, causing FUSCRAC3's critical TDRFs for the
summation over all mobility categories (I-V) to be anywhere from 5 to
10 times lower than those calculated by FUSEDOSE. The reason for
this, as can be seen from Table 4.9, is that the overall largest contri-
butors to the total critical dose for each design are groundshine-
dominated isotopes (i.e., those noted above).
It was decided that such a large difference in groundshine exposure
time warranted further investigation. For 10 groundshine-dominated
isotopes, each of which was one of the overall largest contributors to
the dose for one or more of the seven designs, FUSCRAC3 was run
again using a 10-hour groundshine exposure time. It was found that
for 10-hour groundshine exposure times, the total critical dose
calculated by FUSCRAC3 for these isotopes was within a factor of two
of the doses calculated by Fetter's FUSEDOSE. This extremely
important effect is investigated in detail in Appendix E (please see).
An important secondary effect which also contributes to this trend is
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the difference in the way the codes calculate finite plume correction
factors. FUSCRAC3 utilizes the same finite-plume correction factors
that are found in the original WASH-1400 CRAC code. These factors
were calculated for cloudshine only; nothing was done for groundshine
(i.e., a semi-infinite plume is assumed for groundshine). Furthermore,
the correction factors for cloudshine are calculated as a function of the
plume dimensions only; the energy of the photon was assumed to be
0.7 MeV (typical value for fission isotopes). But a high energy photon
(1-3 MeV) has a much longer mean free path in the plume than a
low-energy photon (0-1 MeV). Hence, for a high-energy photon, the
plume appears smaller than it does to a low-energy photon. Thus,
calculations of the plume size based on a photon energy of 0.7 MeV
lead to overly conservative estimates of the plume volume. The
CRAC code does do a linear extrapolation for higher energy photons,
but the actual dependence of the finite plume corrections upon photon
energy is not linear. Furthermore, the CRAC model does not include
the effect of the Pasquill stability class upon the plume size. For a
class F stability, the plume size is significantly smaller than
semi-infinite. For cloudshine, then, FUSCRAC3 integrates the
concentration of radioactivity over a volume that is much larger than
it should be. Furthermore, because FUSCRAC3 includes no corrections
for groundshine, it integrates over a semi-infinite plume, which for
high energy photons and class F stability is grossly over-conservative.
Fetter, on the other hand, wrote a separate computer code which
calculated finite plume correction factors for both cloudshine and
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groundshine as a function of plume dimensions, stability class, and
photon energy. As a result, the volume integrated over by
FUSEDOSE is significantly smaller (but more realistic) than that inte-
grated over by FUSCRAC3 for both cloudshine and groundshine. This
difference contributes to the fact that the critical doses calculated by
FUSCRAC3 are higher than those calculated by FUSEDOSE for
groundshine-dominated isotopes.
iii) Cloudshine exposure: Both FUSCRAC3 and FUSEDOSE assume an
irradiation time equal to the duration of release. But, for reasons
explained in 4.1, the duration of release for FUSEDOSE calculations
was 10 hours, while for FUSCRAC3, it was three minutes. This
difference would lead to higher cloudshine doses calculated by
FUSEDOSE. This effect is at least partially counteracted, however, by
the difference in finite-plume correction factors described above which
predicts FUSCRAC3s cloudshine doses to be larger than those of
FUSEDOSE. In fact, there is some evidence that this finite-plume
correction factor difference causes FUSCRAC3 to yield higher critical
doses for cloudshine-dominated isotopes. A look at Al-28 and Al-29,
for example, reveals a higher rem/Ci value calculated by FUSCRAC3
than that calculated by Fetter's FUSEDOSE (see Appendix D).
2) Chronic dose: FUSEDOSE does not account for ingestion, while FUSCRAC3
does include ingestion for 145 isotopes. Thus, one would expect a much
larger chronic dose calculated by FUSCRAC3 than that calculated by
FUSEDOSE for ingestion-dominated isotopes such as H-3, Ca-45, P-32,
Fe-55, W-185, and Po-210. (This is confirmed by the data in the table in
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Appendix D.) In fact, Table 4.9 indicates a dramatic difference in doses
calculated by FUSCRAC3 when ingestion is included versus when it is not
included. The differences for ingestion-dominated isotopes range from a
factor of 40 for H-3 up to a factor of 700 for Po-210. It can be seen in
Tables 4.8 and 4.9 that the FUSCRAC3 chronic doses (including ingestion)
for mobility categories II through IV are higher (up to a factor of 5) than
the chronic doses (no ingestion) calculated by FUSEDOSE. (The
FUSCRAC3 TDRFs are therefore lower.) When group V is added in, the
TDRFs calculated by the two codes are very similar due to the fact that, at
the I-V level, much of the dose is a result of isotopes whose chronic dose
commitment from groundshine is higher than that from ingestion (i.e.,
Co-60), and in those cases, the rem/Ci values calculated by the two codes
are similar (i.e., within factors of 2 to 4; see below).
3) Dose conversion factors: The numbers calculated by FUSEDOSE do not
reflect the most up-to-date dose conversion factors used by FUSCRAC3.
Thus, factors of 2 to 4 between the chronic doses calculated by FUSEDOSE
and those chronic doses excluding ingestion, calculated by FUSCRAC3 are
explicable by the differences between the old and new dose conversion
factors.
4) The Ar-42 discrepancy: An unusual situation was discovered for Ar-42:
Fetter's chronic rem/Ci value is 4 orders of magnitude higher than that of
FUSCRAC3's (see Appendix D). Ar-42 has an inhalation dose conversion
factor equal to zero. Furthermore, because it is a noble gas, its deposition
velocity is 0.0 and thus its groundshine dose is zero. It does have a
non-zero cloudshine dose conversion factor, but the majority of its dose
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comes from its daughter, K-42, which does deposit on the ground at a rate of
0.01 m/s. K-42 has a non-zero groundshine dose conversion factor and a
cloudshine dose conversion factor, which is much larger than that of Ar-42. Both
FUSEDOSE and FUSCRAC3 calculate in-cloud decay of parent to daughter, so
the problem is not one of FUSCRAC3's neglecting the daughter dose.
FUSCRAC3's K-42 rem/Ci chronic value is 1.52 x 10-6 and Fetter's is 1.47 x
104 (excellent agreement). FUSCRAC3's rem/Ci value for Ar-42 is roughly five
times lower than that of K-42, whereas Fetter's rem/Ci value for Ar-42 is
roughly 2,000 times higher than that of K-42. The discrepancy can be partially
explained by the large difference in cloudshine exposure times. (FUSCRAC3's
three-minute puff release results in an exposure time 200 times less than that of
ESECOM's 10-hour release. The amount of time that Ar-42 is in the air is
important, because the build-up of K-42 depends on the in-cloud decay of Ar-42.
Now, Ar-42 has a half-life over 20,000 times greater than that of K-42.
(Ar-42's is 33 years; K-42's is 12.4 hours.) Therefore,
A(K-42) - A(Ar-42) ~ A(K-42) (4.2a)
Thus, Equation (2.4e) reduces to:
D1 AD P Apt - D t] (4.2b)
= P0Ap [number less than 1]
Since Ap = A(Ar-42) = 2.4 x 10- hr- 1 , the activity of K-42 is apt
to be small. Thus, while the difference in cloudshine exposure time
may account for a small part of the discrepancy, it certainly does not
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explain a difference of 4 orders of magnitude. It is possible that
Fetter's number reflects an erroneous entry.
4.2.3 Implication of Results for ESECOM Cases
The best way to examine the results is by comparing the data in Tables
4.5, 4.6, and 4.7 (which were generated by FUSEDOSE) with the data in Tables
4.8 and 4.9 from FUSCRAC3. The numbers are different, but all of the differ-
ences can be understood through the detailed explanations found in Section 4.2.2.
The important point to be made is that, although the numbers themselves are
different, the general trends for the TDRFs within each design and between
designs are the same for both sets of data.
For example, for critical doses, Case 5's first wall maintains TDRFs above
unity for all five mobility classes, and Cases 6 and 7 (or 6 and 8 in the
ESECOM study) maintain first wall TDRFs above unity for the first four
mobility categories. Cases 6 and 7 also maintain critical-dose TDRFs above
unity for the balance of the fusion core for the first four mobility categories.
Fetter's chronic dose TDRFs tend to lie between the TDRFs calculated for the
FUSCRAC3 chronic dose with ingestion and without ingestion. In general, for
both FUSEDOSE and FUSCRAC3, the chronic dose TDRFs are significantly lower
than the critical-dose TDRFs, suggesting that efforts will have to be made to
lower the chronic dose.
The effect of the ingestion pathway on the chronic dose is a very prominent
one. It is seen from Table 4.9 that the large inventory of Po-210 from the
Li-Pb coolant breeder in Case 3 contributes an extremely large chronic dose (in
excess of 10 6 rem) due to its high ingestion dose conversion factor. Fe-55, which
is found in large amounts in Cases 1, 2, 3, 4, and 7, also contributes a significant
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dose to the total chronic dose when ingestion is accounted for. And Ca-45 plays
an important role in Cases 1, 4, 6, and 7 due to its large ingestion dose
conversion factor. In Case 5, W-185 becomes a significant isotope when ingestion
is included, as does Na-22.
Thus, it would seem wise to reconsider the choice of LiPb (source of
Po-210) and also perhaps of Li 20 (source of Na-22) as coolant/breeder materials.
Furthermore, it would also be wise to consider structural materials of lower iron
content, lower tungsten content, and lower titanium content (the source of Ca-45)
in order to reduce the effect of ingestion upon the chronic dose, thereby reducing
the chronic dose itself.
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5.0 CONCLUSIONS
The modifications made to FUSCRAC2 in creating FUSCRAC3 were de-
scribed in detail in Chapter 2. The focus of these modifications centered upon
the expansion of the code's capabilities to include 259 radionuclides, as well as
the inclusion of the most up-to-date dose conversion factors and environmental
transfer factors. Several validation procedures were implemented, including the
application of both FUSCRAC2 and FUSCRAC3 to a specific example for the
purpose of direct comparison.
Finally, the new code .was used to generate a comprehensive data base which
includes rem/Ci data for all 259 isotopes based on pessimistic release characteris-
tics. FUSCRAC3 was also applied to the ESECOM study for the purpose of
qualitative comparison with the existing ESECOM accident analysis. It was
determined that the general trends exhibited in the original study remained
unchanged when FUSCRAC3 was applied. Furthermore, it was discovered that
the inclusion of the ingestion pathway in the calculation of the chronic doses
significantly increases the dose for certain isotopes, particularly H-3, Na-22, P-32,
Ca-45, Fe-55, W-185, Re-186, and Po-210. Due to its large inventory in the
majority of cases (all except 5 and 6), the most important of the above isotopes
was Fe-55. However, when the ingestion pathway was excluded, Fe-55 did not
even remain in the top 10% in terms of its contribution to the total chronic dose
for any of the fusion designs. Hence, the use of low-iron-content materials
appears to be particularly important. In addition, the extraordinarily high chronic
dose from Po-Z10 due to ingestion strongly suggests the need to steer away from
Li-Pb coolant/breeder designs.
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Appendix A
BRIEF DESCRIPTION OF FETTER'S DOSE CONVERSION FACTOR FILES
File Name Title/Description Organs Involved
edrcf.1** External Dose-rate Conversion Factors Skin, thymus, lower
for Exposure to a Contaminated Cloud large intestine*,
(rem/sec)(Ci/m 3) small intestine*,
stomach*, upper
large intestine*,
kidneys, liver,
lungs*, muscle,
ovaries*
edref.2** External Dose-rate Conversion Factors pancreas, red
for Exposure to a Contaminated Cloud marrow*, skeleton*,(rem/sec)(Ci/m 3) spleen, testes*,
thyroid*, bladder,
uterus, yellow
marrow, total body*,
EDE+
edrcf.3** External Dose-rate Conversion Factors skin, thymus, lower
Exposure to a Contaminated Plane large intestine*,
(rem/sec)(Ci/m 2) small intestine*,
stomach*, upper
large intestine*,
kidneys, liver,
lungs*, muscle,
ovaries*
edrcf.4** External Dose-rate Conversion Factors pancreas, red
for Exposure to a Contaminated Plane marrow*,
(rem/sec)(Ci/m 2) skeleton*, spleen,
testes*, thyroid*,
bladder, uterus,
yellow marrow,
total body*, EDE+
Internal Dose Conversion Factors:
Rem/Ci Inhaled
Time periods: 2 days, 7 days, 30 days
1 year, 10 years, 20 years, 30 years,
40 years, 50 years
adrenals, brain,
lower large
intestine*, small
intestine*, stomach*,
upper large
intestine*, kidneys,
liver, lungs*,
ovaries*, muscle
idcf.1nb**
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idcf.2nb**
idcf.3nb++
Internal Dose Conversion Factors:
Rem/Ci Inhaled
Time periods: 2 days, 7 days, 30 days,
1 year, 10 years, 20 years, 30 years,
40 years, 50 years
pancreas,marrow*,
skeleton*, spleen,
testes*, thyroid*,
bladder, others,
whole body*,total
body, EDE+
I. .1
Internal Dose Conversion Factors:
Rem/Ci Ingested
Time periods: 2 days, 7 days, 30 days,
1 year, 10 years, 20 years, 30 years,
40 years, 50 years
adrenals, brain,
lower large
intestine*, small
intestine*, stomach*,
upper large
intestine*, kidneys,
liver, lungs*,
muscle, ovaries*
idcf.4nb++ Internal Dose Conversion Factors: pancreas, marrow*,
Rem/Ci Ingested skeleton*, spleen,
Time periods: 7 days, 30 days, 1 year, testes*, thyroid*,
10 years, 20 years, 30 years, 40 years, bladder, others,
50 years whole body*, total
body, EDE+
* indicates organ used by FUSCRAC3
** indicates file used in creating fusdos3
indicates file used in updating fus.i
+ EDE E Effective Dose Equivalent: weighted average of the dose to certain
organs; because FUSCRAC3 uses whole body DCF's, this number is not
needed, since the whole body dose is the dose to the entire body computed
as if all transformations were uniformly distributed throughout the body
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Appendix B
COMPUTER CODES
B.1 Definitions of important variables found in the computer codes:
Step 1
idcf.lnb, idcf.2nb:
fusdos3:
first:
dcflli:
dcffsi:
dcfst:
dcfuli:
dcflun:
dcfov:
dcfmar:
dcfskl:
dcftst:
dcfthy:
dcfwb:
Step 2
second:
temp (i, j, k):
inc (i, j, k):
Step 3
dcftb:
edrcf.1 & edrcf.2:
third:
Fetter's inhalation dose conversion factor data
files (see Appendix A)
This refers to the old fusdos file before ti was
updated; it is used to obtain the isotope array.
This is the data file which STEP1 creates.
Dose conversion factor for the lower large
intestine
Dose conversion factor for the small intestine
Dose conversion factor for the stomach
Dose conversion factor for the upper large
intestine
Dose conversion factor for the lung
Dose conversion factor for the ovaries
Dose conversion factor for the marrow
Dose conversion factor for the skeleton
Dose conversion factor for the testes
Dose conversion factor for the thyroid
Dose conversion factor for the whole body
this is the data file which STEP2 creates
the array containing data for all 9 time period
found in Fetter's files (organ i, time period j,
isotope k)
the final dose conversion factors containing data
for the 7 time periods of interest to FUSCRAC3
(organ i, time period j, isotope k)
dose conversion factor for the total body
external dose rate conversion factor (cloudshine)
files from Fetter (see Appendix A)
this is the data file that STEP3 creates
Step4gd
edrcf.3b & edref.4b:
fourth:
iso(i :
lam (i):
hf(i):
nbr(i):
b1brp(i):
bind i:
bldli 
:Ib1d1h i):
bid2(i):
bid2hf(i):
b2brp(i):
b2nd(i):
b2dl(i :
b2d1hf(i):
b2d2(i):
b2d2hf(i):
it1(i):
It2(i):
epl(i):
ep2(i :
spl8(i):
spl7(i):
bilam1(i):
b1lam2(i):
b2lam1(i):
b2lam2(i):
bllti(i):
bilIt2(i):
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external dose rate conversion factors
(groundshine) from Fetter (see Appendix A)
the data file created by Step4gd
isotope name
decay constant of isotope i
half-life of isotope (i)
number of branches associated with isotope (i)
branch1 branching percent for isotope(1)
branch1 number of radioactive daughters
branchi radioactive daughteri for isotope(i)
branch1 radioactive daughter1 half-life for
isotope(i)
branchi radioactive daughter2 (granddaughter) for
isotope(i)
branchi radioactive daughter2 half-life for
isotope(i)
branch2 branching percent for isotope(i)
branch2 number of radioactive daughters
branch2 radioactive daughteri for isotope(i)
branch2 radioactive daughteri half-life for
isotope(i)
branch2 radioactive daughter2 (granddaughter) for
isotope(i)
branch2 radioactive daughter2 half-life for
isotope(i)
dimensionless number = lambda * time, for time
= 8 hrs for isotope(i)
dimensionless number = lambda * time, for time
= 7 da s for isotope(i)
exp(-At of isotope i or time = 8 hrs
exp(-At of isotope i for time = 7 days
[1 - exp(-At)] for the parent isotope(i) for time
= 8 hrs; the expression contains numerical
methods corrections
[1 - exp(-At)] for the parent isotope(i) for time
= 7 days; the expression contains numerical
methods corrections
decay constant (ln2/t 1 ) for branchi daughteri for
2
isotope(i)
decay constant for branch1 daughter2 for
isotope(i)
decay constant for branch2 daughteri for
daughteri for isotope(i)
decay constant for branch2 daughter2 for
isotope(i)
dimensionless number = lambda * time, for time
= 8 hrs, for branchi daughteri for isotope(i)
dimensionless number = lambda * time, for time
= 7 days, for branchi daughteri for isotope(i)
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b1l2tl(i):
b112t2(i):
b211t1(i):
b211t2(i):
b212t1(i):
b1b212t2(i):
blell(i):
ble12(i):
ble2l i
ble22 i
b2el1 i
b2e12 i
b2e21 I
b2e22 i :
s 18( i):
s17(i):
s28(i):
s27 (i):
count:
sd38h:
sd37d:
sd28h:
sd27h:
sd18h:
sd17d:
brld8h:
brld7d:
br2d8h:
br2d7d:
d(i,1,j):
d(i,2,j):
d(i,3,j):
dimensionless number = lambda * time, for time
= 8 hours, for branchi daughter2 for isotope(i)
dimensionless number = lambda * time, for time
= 7 days, for branchi daughter2 for isotope(i)
dimensionless number = lambda * time, for time
= 8 hours, for branch2 daughteri for isotope(i)
dimensionless number = lambda * time, for time
= 7 days, for branch2 daughteri for isotope(i)
dimensionless number = lambda * time, for time
= 8 hours, for branch2 daughter2 for isotope(i)
dimensionless number = lambda * time, for time
= 7 days, for branch2 daughter2 for isotope(i)
exp(-Ati), where t1 = 8 hours, for branchi,
daughteri, for isotope(i)
exp(-At 2), where t2 = 7 days, for branchi,
dau hter2, for isotope(i)
exp -At, , branchi, daughter2, isotope i
exp -At 2 , branchi, daughter2, isotope i
exp -At, , branch2, daughteri, isotope i
exp -At 2 , branch2, daughteri, isotope i
exp -Atj , branch2, daughter2, isotope i
exp -At 2 , branch2, daughter2, isotope i
dose conversion factor for organ j and isotope i
[1-exp(-Ati)], t1 = 8 hrs, for daugheri; this
calculation is called twice; once for branchi and
once for branch2
[1-exp(-At 2)], t 2 = 7 days, for daughteri, calledfor both branchesL1-exp (-At1 ; daughter2; called for both branches
1-exp(-At 2)]; daughter2; called for both branches
eeps track of which branch is being calculated
8 hr integrated dose from granddaughter; called
for both branches
7 day integrated dose from granddaughter; called
for both branches
8 hr integrated dose from daughter; called for
both branches
7 day integrated dose from daughter; called for
both branches
8 hr integrated dose from parent isotope (i);
called for branches
7 day integrated dose from parent isotope (i);
called for both branches
total branchi 8 hr dose
total branchi 7 day dose
total branch2 8 hr dose
total branch2 7 day dose
total 8 hr integrated groundshine dose conversion
factor for organ(j) and isotope(i)
total 7 day integrated groundshine dose
conversion factor for organ (j) and isotope (i)
dose rate conversion factor ((rem/yr)/Ci/m 2)) for
organ(j) and isotope(i)
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Step 5
fdtrl:
inl (ij,k):
incon(ij,k):
second2:
grcon(ij,k):
clcon(i,k):
Note:
STEP5 created this file, which, after validation,
became fusdos3
inhalation dose conversion factors for isotope(k),
organ(i), and seven cumulative time periods
(0-tacute, 0-1 year, 0-10 years, 0-20 years, 0-30
years, 0-40 years, 0-50 years)
inhalation dose conversion factors for isotope(k),
organ(i), and seven differential time periods
(0-tacute, 0-1 year, 1-10 years, 10-20 years,
20-30 years, 30-40 years, 40-50 years)
a file containing inhalation dose conversion
factors; similar to second, except it contains the
corrected time periods (i.e., 1-10, 10-20, 20-30,
30-40, and 40-50 years)
groundshine dose conversion factor for isotope(k),
organ(i), and time(j), where j=1 is the 8 hr
integrated dose, j=2 is the 7 day integrated dose,
and j=3 is the dose rate
cloudshine dose rate conversion factor for
isotope(k) and organ(i)
The organs are listed in fusdos3 in the following order: lung,
marrow, skeleton, stomach, small intestine, upper large intestine,
lower large intestine, testes, thyroid, ovaries, whole body.
References to organ(j) refer to the jth organ in this list.
Step 6
ingest:
idcf.3nb & idcf.4nb:
ingl(ij,k):
ing(ij,k):
Setup
fusisub:
cfmod:
cf2mod:
orgnam:
beef(i):
milk(i):
this is the ingestion dose conversion factor data
file which STEP6 creates
Fetter's ingestion dose conversion factor data files
(see Appendix A)
ingestion dose conversion factor for organ(k),
isotope(i), and time(j), where j refers to one of 9
time periods from Fetter's files
ingestion dose conversion factor for organ(k),
isotope(i), and time(j), where j refers to one of
the 6 time periods required for FUSCRAC3
(0-50 yrs, 0-10, 10-20, 20-30, 30-40, and 40-50)
data file created by SETUP, which after
validation, replaced the existing chronic section
of the input file
direct environmental transfer factor file (61
indirect environmental transfer factor file 16]
organ name of the jth organ
direct environmental transfer factor for beef for
isotope(i) in Rood's file
direct environmental transfer factor -for milk for
isotope(i) in Rood's file
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crop(i): direct environmental transfer factor for crops for
isotope(i) in Rood's file
beefi(i): indirect environmental transfer factor for beef for
isotope(i) in Rood's file
milki(i): indirect environmental transfer factor for milk for
isotope(i) in Rood's file
cropi(i): indirect environmental transfer factor for crops
for isotope(i) in Rood's file
cr(i): direct environmental transfer factor for crops for
isotope(i) in FUSCRAC3
m(i): direct environmental transfer factor for milk for
isotope(i) in FUSCRAC3
b(i): direct environmental transfer factor for beef for
isotope(i) in FUSCRAC3
cri(i): indirect environmental transfer factor for crops
for isotope(i) in FUSCRAC3
bfmki(i): indirect environmental transfer factor for beef
plus milk in isotope(i) in FUSCRAC3
temp(i,j,k): ingestion dose conversion factor for all 259
isotopes from Fetter's files
ing(l,j,k): ingestion dose conversion factor for those 144
isotopes handled by Rood
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B.2: COMPUTER CODES
c stepi computer code; cray fortran
C
c
c declaration of variables
c
real dcflli(259,9),dcfsi(259.9).dcfst(259.9),dcfuli(259,9).
ldcflun(259,9),dcfov(259,9),dcfmar(259,9),dcfskl(259,9),
2dcftst(259,9),dcfthy(259.9),dcfwb(259,9)
character*8 iso(259)
character*10 time(9)
c
call dropfile(0)
open(unit=2.file-'idcf.lnb',status='old')
open(unit=3,file='idcf.2nb',status='old')
open(unit=4,file-'fusdos3',status='old')
open(unit=5,file='first',status='unknown')
c
c
c assigning isotope names to iso array
read (4,150) (iso(i),i=1,259)
150 format(10a8)
c
c reading dose conversion factors
C
do 10 i-1,259
do 20 j-1,9
read (2,100) dcflli(i,j),dcfsi(i,j),defst(ij).dcfuli(i,j),
ldcflun(i,j),dcfov(i,j)
read (3,110) dcfmor(i,j),dcfskl(i,j),dcftst(i,j),dcfthy(i,j),
ldcfwb(i, j)
100 format(40x,lpelO.2.lpel.2,lpele.2,lpele.2.20x,lpelO.2,10x,
11pe10.2)
110 format(30x,lpelO.2,lpelO.2,10x,lpelO.2.lpelO.2,20xlpelO.2)
20 continue
10 continue
c read time periods
c234567
rewind 2
read(2,55) (time(j),j-1,9)
55 format(10x,a10)
C
C
write(5.300)
300 format(' NUCLIDE ',' TIME ',' LUNG MARROW
1' SKELETON ,' GI:ST ', GI:SI , GI:ULI ',' GI:LLI
2' TESTES ,' THYROID ',' OVARIES , WH BODY ')
C
do 50 i-1,259
do 60 j-1,9
if(j.eq.1) write(5,400) iso(i),time(j),dcflun(i,j),dcfmar(i,j),
ldcfskl(ij),dcfst(i,j),dcfsi(ij),dcfuli(i.j),dcflli(i,j),
2dcftst(i,j),dcfthy(i,j),dcfov(i,j),dcfwb(ij)
c
if(j.ne.1) write(5,500) time(j),dcflun(i.j),dcfmar(i,j),
ldcfskl(i,j),dcfst(ij),dcfsi(i,j),dcfuli(ij),dcfili(i,j),
2dcftst(i,j),dcfthy(ij),dcfov(ij),dcfwb(i,j)
c
C
400 format(a8,2x,alO,lpelO.2,lpelS.2,lpel.2,lpelO.2,lpel. 2.
11pelO.2,1pe10.2,1pe10.2, 1pel.2,1pelG.2,1pe10.2)
500 format(10x,alO,lpelO.2,lpel.2,lpel1.2,1pe10.2,lpel.2,
Ilpel0.2,lpelO.2,lpe10.2,lpelO.2,lpelO.2,lpelO.2)
60 continue
50 continue
stop
end
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c step2 computer code; cray fortran
C
c THIS CODE TAKES CARE OF THE FACT THAT DIFFERENT ORGANS HAVE
c DIFFERENT VALUES FOR THE FIRST TIME PERIOD (SEE CRAC MANUAL)
C
c declaration of variables
C
real temp(11,9.259),inc(11,7,259)
integer ntime(11)
character*8 iso(259)
character.10 hooding(13)
C
call dropfile(0)
open(unit-2,file-'first',status='old')
open(unit=3,file-'fusdos3',status-'old')
open(unit=4,file='second',status'unknown')
C
c iVitializing ntime array to zero
C.
do 15 n- 1,11
ntime(n) - 0
15 continue
C
c assigning isotope names to iso array
read (3,150) (iso(i),i-1,259)
150 format(10o8)
c reading in information from first
C
read(2,155) (heoding(c),c-1,13)
155 format(13o10)
do 50 k-1,259
do 40 j=1,9
read (2,160) (temp(ij,k), i=1,11)
160 format(20x,1pe10.2,lpe10.2,1pe10.2,1po10.2,1po10.2,1pe10.2,
11pel.2.lpelO.2,1pelO.2,lpelO.2,lpelO.2)
40 continue
50 continue
C
C
do 70 k-1,259
do 80 j- 1,9
do 90 i- 1,11
if (j.eq.1) go to 101
if (j.eq.2) go to 102
if (j.eq.3) go to 103
if (j.eq.4) go to 104
if (j.ge.5) go to 105
90 continue
80 continue
do 12 m-1,11
ntime(m)-0
12 continue
70 continue
go to 21
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C
c go to subsection
C
101 if (i.ie.7) go to 110
ntime(i) = ntime(i) + 1
inc(i,ntime(i),k) = temp(i,j,k)
110 go to 90
102 if (i.eq.1) go to 130
if (i.ge.8) go to 130
ntime(i) = ntime(i) + 1
inc(i,ntime(i).k) = temp(ij,k)
130 go to 90
c skip 30 day time period
103 go to 90
C
104 if (i.eq.1) go to 170
ntime(i) = ntime(i) + 1
inc(i,ntime(i),k) = temp(i.j,k)
go to 90
170 ntime(i) = ntime(i) + 1
inc(i,ntime(i),k) = temp(i,j,k)
ntime(i) - ntime(i) + 1
inc(i.ntime(i),k) = temp(ij,k)
go to 90
105 ntime(i) = ntime(i) + 1
inc(i,ntime(i),k) = temp(i,j,k)
go to 90
C
C
c wr
c
iting to file called second
21 write(4,300)
300 format(' NUCLIDE ','TIME INDEX',' LUNG ',' MARROW
1' SKELETON ',' GI:ST ', GI:SI ', GI:ULI ',G'
2' TESTES ',' THYROID ',' OVARIES ',' WH BODY ')
do 25 k - 1,259
do 35 j - 1,7
if (j.eq.1) write(4,500) iso(k),j.(inc(i,j.k), i-1.11)
if (j.ne.1) write(4,600) j,(inc(ij,k), i-1,11)
500 format(o8,2x,5x,11,4x.1pelO.2,lpelO.2,1pe10.2,1pe10.2.
11pelO.2,lpelO.2,lpel.2,lpelO.2 ,lpelO.2,lpelO.2,lpel.2)
600 format(lx,5x.I1,4x,lpelO.2,lpelO.2.lpelO.2.lpelO.2.
11pelO.2,1pelO.2,1pelO.2.1pelO.2,1pelO.2,1pelO.2,1pelO.2)
35 continue
25 continue
stop
end
I: LLI
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c step3 computer code; cray fortran
C
c THIS PROGRAM TAKES CARE OF EXTERNAL RADIATION FROM CLOUDSHINE
c
c declaration of variables
real dcflli(259),dcfsi(259),dcfst(259),dfuli(259),dcflun(259),
ldcfov(259).acfmar(259).dcfskl(259),dcftst(259),dcfthy(259),
2dcftb(259)
character*8 iso(259)
c
call dropfile(e)
open(unit-2,file-'edrcf.1',status-'old')
open(unit-3,file-'edrcf.2',status-'old')
open(unit-4,file-'fusdos3',status-'old')
open(unit-5,file-'third',status-'unknown')
c
c assigning isotope names to iso array
read(4,150) (iso(i), i-1,259)
150 format(10a8)
c
c read dose conversion factors
do 10 i-1,259
read(2,1eO) dcfili(i),dcfsi(i),dcfst(i),dcfuli(i),dcflun(i),
ldcfov(i)
read(3,110) dcfmar(i),dcfskl(i),dcftst(i),dcfthy(i),dcftb(i)
100 format(37x,lpele.2,lpelS.2,lpele.2.1pelO.2,20x,lpelO.2,
110x,1pe1e.2)
110 format(27x,lpelO.2.lpel.2,10x,lpelO.2.lpelO.2.30xlpelO.2)
10 continue
c
c write to third
c
write(5,300)
300 format(' NUCLIDE ,' LUNG ',' MARROW ',' SKELETON
1' GI:ST ',' GI:SI ',' GI:ULI ,' GI:LLI ',' TESTES
2' THYROID ',' OVARIES ',' TOT BODY ')
do 50 i-1,259
write(5,400) iso(i),dcflun(i),dcfmar(i).dcfski(i),dcfst(i),
ldcfsi(i),dcfuli(i),dcfili(i),dcftst(i),dcfthy(i),dcfov(i),
2dcftb(i)
400 format(a8.2x.lpele.2.1pe10.2.1pelO.2,lpe10.2.lpel.2.1pele.2,
11pelO.2,1pelO.2,lpelS.2.1pelO.2.1pele.2)
50 continue
stop
end
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- hflife2 data file; p.1
NUCLIDE HFLF (s) nbr brperc nd doughti d1hflife daug't2 d2hflife
h-3 3.89e+08 1 1.0000 0 xxxxxxxx e.oeo+oe xxxxxxx 0.00e+ee
be-7 4.61e+06 1 1.000 0 xxxxxxxx 0.00e+00 xxxxxxxx 0.00e+00
be-10 5.05e+13 1 1.0eee 0 xxxxxxxx 0.00e+ee xxxxxxxx 0.000+00
c-14 1.81e+11 I 1.oeee e xxxxxxxx o.eoe+e xxxxxxxx 0.000+00
n-13 5.98e+02 1 1.0000 0 xxxxxxxx o.eoe+ee xxxxxxxx 0.00e+00
n-16 7.13e+00 1 1.oeeo o xxxxxxxx e.e0e+e xxxxxxxx e.oee+oe
f-18 6.59e+03 1 1.0ee 0 xxxxxxxx e.eee+ee xxxxxxxx 0.00ee+o
no-22 8.21e+07 1 1.oeee xxxxxxxx o.pee+oe xxxxxxxx e.ea.+o
no-24 5.41e+04 1 1.0000 e xxxxxxxx e 0.e+00 xxxxxxxx 0.eee+00
mg-27 5-.68e+02 1 I.eoeo e xxxxxxxx 0.00e+oo xxxxxxxx e.ee+00
mc-28 7.56e+04 1 1.060 1 al-28 1.34e+02 xxxxxxxx e.00e+00
ai-26 2.27e+13 1 1.0060 0 xxxxxxxx 0.00e+00 xxxxxxxx e.00e+ee
ol-28 1.34e+02 1 1.0600 6 xxxxxxxx e.0o.+ee xxxxxxxx e.00.+e0
al-29 3.96e+02 1 1.0060 6 xxxxxxxx 0.06o+00 xxxxxxxx e.eOe+0
si-31 9.43e+03 1 1.0060 0 xxxxxxxx 0.060+00 xxxxxxxx 0.000+00
si-32 2.e5e+10 1 1.000 1 p-3 2 1.23e+06 xxxxxxxx 0.06.+00
p-32 1.23e+06 1 1.000 0 xxxxxxxx 0.990+89 xxxxxxxx 0.060+0
p-33 2.19e+06 1 1.0000 0 xxxxxxxx 0.006+06 xxxxxxxx 0.000+00
s-35 7.55e+06 1 1.0060 0 xxxxxxxx 0.06.+0 xxxxxxxx 0.00.+00
s-37 3.00e+e2 1 1,0069 0 xxxxxxxx 0.06+00 xxxxxxxx 0.004+06
cl-36 9.46e+12 1 1.0660 0 xxxxxxxx 0.06.+0 xxxxxxxx 0.00.+00
cI-40 8.10e+01 1 1.0006 0 xxxxxxxx 0.06.+06 xxxxxxxx 0.00ee+0
or-39 8.48e+09 1 1.0666 0 xxxxxxxx 0.06.+00 xxxxxxxx 6.60o+60
ar-41 6.59e+03 1 1.0006 0 xxxxxxxx 0.06.+00 xxxxxxxx 6.06.+00
ar-42 1.04e+09 1 1.0000 1 k-42 4.45.+04 xxxxxxxx 0.00406+
k-40 4.04e+16 1 1.0006 0 xxxxxxxx 0.00+.6 xxxxxxxx 6.060+00
k-42 4.45e+04 1 1.0000 0 xxxxxxxx 0.0e+00 xxxxxxxx 6.06+00
k-43 8.03e+04 1 1.000 6 xxxxxxxx 0.0006+ xxxxxxxx 0.00.+00
co-41 3.15e+12 1 1.0600 0 xxxxxxxx 0.000+09 xxxxxxxx 0.00+00
co-45 1.43e+07 1 1.0666 6 xxxxxxxx 0.00.+00 xxxxxxxx 6.66.+00
co-47 3.92e+05 1 1.000 1 sc-47 2.95e+05 xxxxxxxx 0.00.+00
sc-44 1.41e+04 1 1.0000 0 xxxxxxxx 0.0.+0 xxxxxxxx 0.06.+00
sc-44m 2.11e+05 2 0.8139 0 xxxxxxxx 0.000+0 xxxxxxxx 0.00+00
0.9861 1 sc-44 1.41e+04 xxxxxxxx 0.06.+0
sc-46 7.24e+06 1 1.0000 6 xxxxxxxx 0.00+00 xxxxxxxx 0.00.+00
sc-4 7  2.95.+05 1 1.0000 6 xxxxxxxx 0.00+00 xxxxxxxx 0.00.06+
sc-48 1.57e+05 1 1.0000 0 xxxxxxxx 0.66.+0 xxxxxxxx 0.00.+00
sc-49 3.42e+03 1 1.0000 xxxxxxxx 0.06.+0 xxxxxxxx 6.00.+6
3c-59 1.03e+02 1 1.0060 0 xxxxxxxx 0.00.06+ xxxxxxxx 0.66.+00
ti-44 1.48e+09 1 1.0000 1 sc-44 1.41@+04 xxxxxxxx 0.60400
ti-45 1.11.+04 1 1.0060 0 xxxxxxxx 0.000+6o xxxxxxxx 0.00+00
ti-51 3.48*+02 1 1.6006 6 xxxxxxxx 0.00.+00 xxxxxxxx 0.000+6
v-48 1.38.+06 1 1.0000 0 xxxxxxxx 6.000+ xxxxxxxx 0.06.+o0
v-49 2.85.+07 1 1.6000 6 xxxxxxxx 0.00.+00 xxxxxxxx 0.000+00
v-52 2.26.+02 1 1.0000 6 xxxxxxxx 0.600+00 xxxxxxxx 0.004e00
v-53 9.60+1 1 1.6000 0 xxxxxxxx 0.00+00 xxxxxxxx 8.0.+0
cr-49 2.51e03 1 1.000 1 v-49 2.85e+07 xxxxxxxx 0.0.00
cr-51 2.39.+06 1 1.0000 0 xxxxxxxx 0.00e+00 xxxxxxxx 6.00.+0
cr-55 2.13.+02 1 1.0600 6 xxxxxxxx 0.00.+00 xxxxxxxx 6.000+40
mn-52 4.83e+05 1 1.0000 0 xxxxxxxx 0.000+00 xxxxxxxx 0.08+00
mn-52m 1.27.+03 1 1.0600 0 xxxxxxxx 0.690+00 xxxxxxxx 0.000+00
mn-53 1.17e+14 1 1.0000 0 xxxxxxxx 0.00+0 xxxxxxxx 0.000+00
mn-54 2.70.+07 1 1.000, 6 xxxxxxxx 0.0.o+0 xxxxxxxx 0.0.400+
mn-56 9.28.+3 1 1.0600 6 xxxxxxxx 0.06.+0 xxxxxxxx 0.0.e+0
mn-57 9.60s+91 1 1.6666 0 xxxxxxxx 0.06.+06 xxxxxxxx 0.000
fe-53 5.11.+2 1 1.000 1 an-53 1.17e+14 xxxxxxxx 6.000+00
fe-55 8.51+07 1 1.00 xxxxxxxx .oe.+eo xxxxxxxx 0.00e+00
f0-59 3.85e+06 1 1.0000 0 xxxxxxxx 0.000+00 xxxxxxxx 0.00+00
fe-68 9.46e+12 1 1.0000 2 co-60m 6.30.+2 co-60 1.669+08
co-57 2.34.+07 1 1.6000 0 xxxxxxxx 0.06.+0 xxxxxxxx 6.0004+
co-58 6.12e+06 1 1.0000 0 xxxxxxxx 0.00.+0 xxxxxxxx 0.00e+00
co-58m 3.31e+04 1 1.0000 1 co-58 6.12.e66 xxxxxxxx 0.00400
co-60 1.66e08 1 1.0000 6 xxxxxxxx 0.00.+00 xxxxxxxx 0.000+00
co-60m 6.30+02 1 1.0000 1 co-60 1.66.+08 xxxxxxxx 0.000+06
co-61 5.94*+03 1 1.006 0 xxxxxxxx 0.00+00 xxxxxxxx 0.00.40+
co-62m 8.34.+02 1 1.0000 0 xxxxxxxx 0.06+00 xxxxxxxx 0.000+00
ni-57 1.30.+05 1 1.000 1 co-57 2.34*+07 xxxxxxxx 0.000+00
ni-59 2.37.+12 1 1.0000 0 xxxxxxxx 0.000+80 -xxxxxxx 6.000+00
ni-63 3.15.e9 1 1. 0000 0 xxxxxxxx 0.060+0 xxxxxxxx 0.00+0
ni-65 9.07*+03 1 1.0000 0 xxxxxxxx 0.00+00 xxxxxxxx 0.00+00
84
--- hflife2 data
cu-62 5.84e+02
cu-64 4.57e+04
cu-66 3 06e+02
zn-63 2 29e+03
zn-65 2.11e+07
zn-69 3.36e+03
zn-69m 5.04e+04
as-74 1.54e+06
as-76 9.47e+04
se-75 1 02o+07
se-79 2.05o+12
kr-81 6.62e+12
kr-85 3.37s+08
kr-87 4,56.+03
kr-88 1.02e+04
rb-86 1.62e+06
rb-86m 6.12e+1
rb-87 1.51e+18
rb-88 1.07e+03
sr-89 4.36e+06
sr-9S 9.08e+08
sr-91 3.42.+04
y-88 9.21e+06
y-90 2.31e+5
y-90m 1.15*+0
y-91 5.05.+06
y-91m 2.98.+03
y-92 1.27e+04
y-93 3.67e+4
y-94 1.12"+43
zr-89 2.829+05
zr-93 4.73e+13
zr-95 5.53.+"6
zr-97 6.08+4
nb-9e 5.26e+84
nb-9' 8.66E+14
nb-91m 5.36"+46
nb-92 1.010+15
nb-92m 8.77.+45
nb-93m 4.295+
nb-94 6.31.+11
nb-94m 3.76e+02
nb-95 3,02.+"6
nb-95m 3.13.+45
nb-96 8.42.+04
nb-97 4.32e+03
nb-97m 6.00"+41
nb-98m 3.6+03
mo-91 9.29.+2
mo-93 9.46.+10
mo-93m 2.48.+04
nro-99 2.38e+5
mo-101 8.76.+2
tc-97 8.20e+13
tc-98 1.32*+14
tc-99 6.75e+12
tc-99m 2.17e+04
tc-11 8.58+"2
ru-103 3.46*+.6
ru-l5 1'.60.E04
ru-106 3.17e+07
rh-101 1.04"+8
rh-10im 3.75e+5
rh-103m 3.37o+03
rh-105 1.27"+45
pd-107 2.05e+14
pd-l9 4.83.e4
pd-ill 1.32e+03
file; p.2 -
1 1.0000 0
1 1e. ee
1 1.0000 0
1 .0000 0
1 1.0000 0
1 1.eee 0
1 1.0066 1
1 1.ee e
1 10000 0
1 10000 61 1.0000
1 1.0000 0
1 106 0
1 1.000 0
1 .o0ee 1
1 1.0006 0
1 1.0006 1
1 10006 8
1 1.0606 0
1 1.0000 0
1 1.0000 1
2 0.5700 2
0.4300 1
1 10006 0
1 1.006 0
1 1.000 1
1 10000 6
1 1.00e 1
1 1.0066 0
1 1.0666 2
1 1.0066 6
1 1.0666 6
1 1.000 1
1 1.0006 1
1 1.0000 1
1 1.e666 0
1 1.006 0
1 1.000 1
1 1.06 6
1 1.0000
1 1.006 0
1 1.0600 a
1 1.6666 1
1 1.6666 0
1 1.000 1
1 1.666s 0
1 1.0000 6
1 1.0000 1
1 1.000 6
1 1.0600 1
1 1.000 1
1 1.00 2
2 0.8700 2
0. 1300 1
1 1.6600 1
1 1.000 0
1 1.6600 0
1 1.6000
1 1.0000 1
1 1.60 0
1 1.000 1
1 1.0000 1
1 1.00 
1 1.666 0
2 0.0800 1
0.920 0
1 1.00 0
1 1.000 6
1 1.0660 0
1 1.0000 0
1 1.0006 1
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
zn-69
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
rb-88
xxxxxxxx
rb-86
xxxxxxxx
xxxxxxxx
xxxxxxxx
y-90
y-91m
y-91
xxxxxxxx
xxxxxxxx
y- 90
xxxxxxxx
y-91
xxxxxxxx
zr-93
xxxxxxxxx
xxxxxxxx
nb-93m
nb-95
nb-97
xxxxxxxx
xxxxxxxx
nb-91
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
nb-94
xxxxxxxx
nb-95
xxxxxxxx
xxxxxxxx
nb-97
xxxxxxxx
nb-91
nb-93m
mo-93
tc-99m
tc-99
tc-161
xxxxxxxx
xxxxxxxx
xxxxxxxx
tc-99
xxxxxxxx
rh-183m
rh-105
xxxxxxxx
xxxxxxxx
rh-191
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
Gg-111
0.000+00
3. 00.406
0.000+00
000e+9C.
0 0+ 0
0.000+00
3. 36e+43
0.000+09aeeo+oo
1. 07o+e0
0.06o+44
0.0.00
0.620 06
0.000+09
0.000+00
1.7e+03
0.00.+06
I .E2e+46
0.00o+06
0.000+00
0.000+00
2.31.+5
2.9803
5.65e+6
0.00+00
0.000+00
0.000+00
4. 29*+06
3.02"+60
4.73e+13
0.000+00
0.000+00
4.29.+48
3.82.+46
4.32.+43
0. 06.+06
8. 660+14
0.060+8
0.66o+46
0.000+00
0.060+00
6.310+11
0.660+00
3.02*+06
0.e000+0
6.06.+90
4.32s+03
0.66.+0
8.660+14
4.29o+8
9. 460+16
2.17e+04
6.75.+12
8.58.+02
0.060+0
0. 000
0.660+00
6. 750+12
0.090+00
3.3703
1.27.+05
0.04+06
0.86+88
1.04.+8
.00.40+0
0.000+00
0.000+00
0.000+9
0.000+6
6. 44*+05
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
y-91
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
nb-930
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
nb-930
tc-99
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
xxxxxxxx
0.000+00
0.0ee+e0
0. 000+00
0.6oe+00
0. ee.+oe0.O0o+00
0.060+000.8e+0
0.00+00
0. 06e+00
0.06.+00
0.86.+0
0.000+00
0.00.+00
0.00o+40
0.eoo+06
0.00.+46
0.00e+40
8. 00.060
0.00o+46
6.60.+40
5.05.+46
0.66.+46
0.66.+46
0. 66.+00
0.06.+46
0.66.+46
6.66.446
6.06.440
4.29.+68
0.60.4+6
0.66.+40
6.00.400
6.86.+46
6.06.+00
6.66.446
0. 000446
0.66.+06
0.66.446
0.66.446
0.660+06
6.000+40
6.60.+00
6.00.+46
6.604460
60.446+
0.446+
6.00.446
0.00.+00
0.66.+40
0.000+40
4. 2908
6.75.+12
6.66.+00
0.60.4+4
6.66.+00
0.660+00
0.06.+00
0.00.+00
6.60.446
6.ea0+00
6.66.+00
6.00.+00
0.00o+00
6.000+00
6. 00+400
6.00.+40
6.00.+40
6. 00o+40
6.00.+40
6.600+00
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- hflife2 data file; p.3
pd-111m 1.98e+04 1 1.0000 2 pd-111 1.32e+03 ag-111 6.44e+05
ag-108 1.44e+2 1 1.0000 xxxxxxxx e.oee+e e xxxxxxxx e.ee.+e
ag-108M 4.Oe+e9 2 0.0870 1 ag-1i8 1.44.+02 xxxxxxxx 0.0000
0.9130 a xxxxxxxx 0.000+e xxxxxxxx 0.000+00
ag-110 2.44e+01 1 1.0000 e xxxxxxxx ee.ooe+e xxxxxx e.ee.+ee
og-11om 2.18e+07 1 1.0000 0 xxxxxxxx O.ee+eo xxxxxxxx 0.000+ee
ag-111 6.440+05 1 1.0000 0 xxxxxxxx 6.66.+00 xxxxxxxx 6.000+09
cd-109 3.91e+07 1 1.9ee a xxxxxxxx e.ee.+o xxxxxxxx e.ee*+oo
cd-113M 4.42e+08 1 1.eseo e xxxxxxxx e.oe.+e0 xxxxxxxx e.eeo+oo
cd-115 1.92.e5 1 1.6606 2 in-115m 1.62.+04 in-115 1.61o+22
in-114 7.19e+01 1 1.000 e xxxxxxxx e.ee+0 xxxxxxxx 6.66.+0
in-114 4.284e+6 1 i.eeee I in-114 7.194e1 xxxxxxxx 0.006+00
in-115 1.61.+22 1 1.0666 e xxxxxxxx 6.6e.+eO xxxxxxxx 6.66.+00
in-115m 1.62e+04 1 1.0000 1 in-115 1.61e+22 xxxxxxxx e.ee.+o
in-116 1.41e+01 1 1.8ee 0 xxxxxxxx 0.00o+00 xxxxxxxx 6.00e+00
in-116m 3.25e+03 1 i.ee 0 xxxxxxxx 0.00e+Oe xxxxxxxx 0.0ee+oo
sn-113 9.94e+06 1 1.0009 e xxxxxxxx .oee+ee xxxxxxxx e.eoe+oo
3n-113m 1.26.+03 1 1.0000 1 sn-113 9.94o+06 xxxxxxxx e.eo.+oo
sn-121 9.76e+4 1 1.806 6 xxxxxxxx e.ee.+eO xxxxxxxx 6.66.+00
sn-121m 1.73e+09 2 e.2240 6 xxxxxxxx 6.o66+06 xxxxxxxx 6.60400+
0.7760 1 sn-121 9.76e+04 xxxxxxxx 0.G0.e+S
sn-123 1.11e+07 1 1.0000 e xxxxxxxx 0.00"+o6 xxxxxxxx 0.000+00
sn-126 3.15e+12 2 0.8609 1 sb-126m 1.144e3 xxxxxxxx 6.e0e+40
0:1400 2 sb-126m 1.14.+03 sb-126 1.67e+06
sb-122 2.32e+05 1 i.eoe e xxxxxxxx 6.66.+0 xxxxxxxx 6.66.+06
sb-124 5.20e+86 1 i.eeee e xxxxxxxx 6.86.00+ xxxxxxxx 6.6000+
sb-125 8.51e+07 2 0.2300 1 te-125m 5.01e+06 xxxxxxxx 0.0eo00+
0.7700 0 xxxxxxxx 0.0.00+ xxxxxxxx 6.604+00
sb-126 1.07.+06 1 1.060 0 xxxxxxxx 0.00.+00 xxxxxxxx 0.004+00
sb-126m 1.14.+03 2 0.8600 0 xxxxxxxx 6.66.+00 xxxxxxxx 6.00.+00
0.1400 1 sb-126 1.87e06 xxxxxxxx 0.00+00
sb-129 1.58.+04 1 1.606 2 t.-129 4.14.+03 i-129 5.05.+14
to-125m 5.01e+06 1 1.6000 0 xxxxxxxx 6.666+00 xxxxxxxx 0.0e+00
t.-129 4.14e+03 1 1.0000 1 i-129 5.05.+14 xxxxxxxx 0.00e+00
t.-129m 2.89e+06 2 0.6340 2 to-129 4.14.+03 i-129 5.05.+14
0.3660 1 i-129 5.65.+14 xxxxxxxx 0.00+00
to-131 1.50.+03 1 1.0000 1 i-131 6.95.+05 xxxxxxxx 0.00.+40
te-131M 1.08.+05 2 0.2200 2 to-t31 1.50.+03 i-131 6.95.+05
0.7800 1 i-131 6.95.+05 xxxxxxxx 6.006+00
t.-132 2.81.05 1 1.0000 1 i-132 8.21e+03 xxxxxxxx 8.0.*+4
i-129 5.05*+14 1 1.0600 6 xxxxxxxx 6.00.06+ xxxxxxxx 6.0.o+0
i-131 6.95e+05 1 1.0000 6 xxxxxxxx 9.000+ xxxxxxxx 0.0.00+
i-132 8.21.+03 1 1.0006 0 xxxxxxxx 0.66.+00 xxxxxxxx 0.00.+0
i-133 7.52.+04 1 1.0666 1 xe-133 4.54*+05 xxxxxxxx 6.60.+00
i-134 3.16.+03 1 1.0000 6 xxxxxxxx 6.000 xxxxxxxx 6.6000
i-135 2.38.+04 1 1.0000 2 x.-135 3.2804 cs-135 9.46.+13
xe-133 4.54.+05 1 1.0000 6 xxxxxxxx 6.8006+ xxxxxxxx 0.0e+00
xe-135 3.28.+04 1 1.800 1 cs-135 9.46.+13 xxxxxxxx 6.0006+
cs-134 6.5he+07 1 1.6666 0 xxxxxxxx 6.000+ xxxxxxxx 0.06.+4
cs-135 9.46*+13 1 1.060 0 xxxxxxxx 6.66.+00 xxxxxxxx 0.6000+
cs-136 1.13.+06 1 1.000 0 xxxxxxxx 6.0.+06 xxxxxxxx 0.00.06+
cs-137 9.510+06 1 1.006 0 xxxxxxxx 0.0.+60 xxxxxxxx 6.00.06
ba-133 3.37.+00 1 1.0600 0 xxxxxxxx 0.000+ xxxxxxxx 0.00.+00
ba-140 1.11.+06 1 1.0060 1 18-140 1.45.+05 xxxxxxxx 6.0e+00
Ia-137 1.89.+12 1 1.0600 0 xxxxxxxx 6.00.+00 xxxxxxxx 0.66.+00
la-138 3.47.+18 1 1.6600 6 xxxxxxxx 6.006+ xxxxxxxx 6.006+
la-140 1.45.+05 1 1.0060 0 xxxxxxxx 0.000+ xxxxxxxx 0.406e+
ce-144 2.45e+07 1 1.0066 o xxxxxxxx 0.00e+06 xxxxxxxx 0.00.+00
pm-145 5.58.e08 1 1.006 xxxxxxxx 0.600+96 xxxxxxxx 0.000+6s
pm-146 1.73e+08 2 0.6610 6 xxxxxxxx 6.00+00 xxxxxxxx 6.0006
0.3390 1 esm-146, 3.25.+15 xxxxxxxx 6.00+00
sm-146 3.25.+15 1 1.6000 0 xxxxxxxx e.000+00 xxxxxxxx 0.0.+00
sm-147 3.34.+18 1 1.6666 0 xxxxxxxx 6.00e+06 xxxxxxxx 0.00.+00
3M-151 2.84e09 1 1.6000 6 xxxxxxxx 0.000+ xxxxxxxx 0.006+06
eu-150 1.14.e09 1 1.906 0 xxxxxxxx 6.00.+0 xxxxxxxx 0.604+0
ou-152 4.10e+e0 1 1.6006 0 xxxxxxxx 0.60.06+ xxxxxxxx a.60e+0
eu-154 2.68e08 1 1.6060 0 xxxxxxxx 0.60e+00 xxxxxxxx 0.0
gd-148 3.09.+09 1 1.0660 o xxxxxxxx 6.60.00+ xxxxxxxx 0.00+00
gd-150 5.68.+13 1 1.066 1 sr-146 3.256+15 xxxxxxxx 6.00.+66
tb-157 4.73e+09 1 1.6660 6 xxxxxxxx 6.066+00 xxxxxxxx 6.00406+
tb-158 4.73@+09 1 1.6000 0 xxxxxxxx 6.66.+06 xxxxxxxx 6.000+
86
- hflife2 data file; p.4
dy-154 4.68e+04 1 1.00H 2 gd-15e 5.68e+13 sm-146 3.25e+15
ho-166 9.65e+04 1 1 .eee 0 xxxxxxxx e.oee+oo xxxxxxxx e.eoe+ee
lu-1 7 6  1.14e+18 1 1.ooeo o xxxxxxxx o.oo+e xxxxxxxx l0.00e+00
lu-177 5.800+05 1 i.eeoo e xxxxxxx e.oe+oo xxxxxxxx 0.Oie+00
lu-177m 1.39e+07 2 0.780e 0 xxxxxxxx 0.O6.+00 xxxxxxxx 0.00*+00
0.2206 1 lu-177 5.80e+05 xxxxxxxx 0.00e+00
lu-178 1.70e+03 1 1.ooes a xxxxxxxx .eo.+.o xxxxxxxx e.eo.+oo
lu-178m 1.38e+03 1 1.es 6 xxxxxxxx e.ee.+oo xxxxxxxx e.oo.+oo
hf-175 6.05e+06 1 1.000 a xxxxxxxx 0. 0+00 xxxxxxxx 0.000+00
hf-178m 9.78e+08 1 1.0000 0 xxxxxxxx e.eee+ee xxxxxxxx e.oo.+e
hf-181 3,66e+06 1 1.0060 6 xxxxxxxx e.eo+.o xxxxxxxx 8 090+0o
hf-182 2.84e+14 1 1.000e 1 to-182 9.94e+06 xxxxxxxx 0.00.+6
hf-183 3.84.+03 1 1.606 1 to-183 4.41e+05 xxxxxxxx 0.006+06
to-179 5.36e+07 1 1.0066 e xxxxxxxx 0.000+0 xxxxxxxx 6.00+00
to-180m 2.92e+04 1 1.0.0, 6 xxxxxxxx 6.06.+eo xxxxxxxx 0.0.e+0
to-182 9.94e+06 1 1.0000 0 xxxxxxxx 0.000+00 xxxxxxxx 0.66.+00
to-182m 9.50*+02 1 1.060 1 to-182 9.94.e6 xxxxxxxx 6.000+00
to-183 4.41e+05 1 1.0000 0 xxxxxxxx 0.60e+06 xxxxxxxx 0.00e+40
to-184 3.130+04 1 1.0860 0 xxxxxxxx 0.66.+06 xxxxxxxx 6.60o+40
to-185 2.94.+03 1 1.0000 1 w-185 6.49.+06 xxxxxxxx 0,.9+e0
to-186 6.30o+02 1 1.0060 0 xxxxxxxx 60.0+o xxxxxxxx 0.00.+0
w-179 2.28.+03 1 1.0006 1 to-179 5.36*+07 xxxxxxxx 0.000+
w-179m 3.84e+02 2 0.9969 2 w-179 2.28e+3 to-179 5.36e+97
0.0031 1 to-179 5.36e+07 xxxxxxxx 0.06.+4
w-181 1.65e+07 1 1.0006 0 xxxxxxxx 6.00.+6 xxxxxxxx 0.60.+e0
w-185 6.49e+6 1 1.006 6 xxxxxxxx 0.00.+6 xxxxxxxx 6.60e+e0
w-187 8.60.e4 1 1.0000 1 re-187 1.26.+18 xxxxxxxx 6.e0e+00
W-188 6.06.+06 1 1.0060 1 re-lBS 6.08+04 xxxxxxxx 6.600+00
re-186 3.27e+05 1 1.0000 0 xxxxxxxx 6.6e+0 xxxxxxxx 0.00.+00
re-186m 6.31.+12 1 1.0600 1 ro-186 3.27.+5 xxxxxxxx 0.600+00
re-187 1.26e+18 1 1.0000 0 xxxxxxxx 0.00e+0 xxxxxxxx 6.000+60
re-188 6.08e+04 1 1.0000 0 xxxxxxxx 0.00.+0 xxxxxxxx 0.00.+00
re-188m 1.12.+03 1 1.0060 1 re-188 6.08o+4 xxxxxxxx 6.600+00
re-189 8.75e+64 2 6.8950 6 xxxxxxxx 60.44o+6 xxxxxxxx 0.e0.+00
0.1950 1 os-189m 2.05.e4 xxxxxxxx 6.0.40
os-189m 2.05.e4 1 1.6000 6 xxxxxxxx 6.00.+6 xxxxxxxx 0.6006+
os-194 1.89.+08 1 1.0600 1 ir-194 6.91.e4 xxxxxxxx e.66.+00
ir-192 6.41e+6 1 1.6600 e xxxxxxxx 0.eoe+06 xxxxxxxx 0.000+00
ir-192m 7.60.+09 1 1.0000 1 ir-192 6.41e+06 xxxxxxxx 0.06.+0
ir-194 6.91e+04 1 1.0000 0 xxxxxxxx 0.Oee+06 xxxxxxxx 0.00.+0
pt-190 1.89#+19 1 1.0000 0 xxxxxxxx 0.00.+0 xxxxxxxx 6.00.+0
pt-193 1.580+06 1 1.0600 0 xxxxxxxx 0.0e+00 xxxxxxxx 0.000+00
pt-193m 3.72.+05 1 1.000 1 pt-193 1.580+09 xxxxxxxx 6.00e+0
au-194 1.42.+05 1 1.6600 6 xxxxxxxx 6.660+66 xxxxxxxx 0.60.+06
ou-198 2.33.+05 1 1.006 6 xxxxxxxx 0.C0+00 xxxxxxxx 6.600+06
hg-194 1.64*+16 1 1.6000 1 au-194 1.42.+05 xxxxxxxx 6.060+00
hg-203 4.64.+06 1 1.0066 6 xxxxxxxx 0.000+00 xxxxxxxx 0.000+G
hg-265 3.12e+02 1 1.6666 0 xxxxxxxx 0.6000+ xxxxxxxx 0.6000+
tI-262 1.05.+06 1 1.0066 e xxxxxxxx 6.00.+00 xxxxxxxx 0.600+00
tI-264 1.19.+08 1 1.000 0 xxxxxxxx 0.66.400 xxxxxxxx 0.06.+06
tI-206 2.52.+02 1 1.6660 6 xxxxxxxx 0.600+00 xxxxxxxx 6.60.+06
pb-202 9.46.+12 1 1.6000 1 tl-262 1.05.+06 xxxxxxxx 60.00+00
pb-203 1.87.+05 1 1.06m 6 xxxxxxxx 0.600+06 xxxxxxxx 0.0.400+
pb-265 4.420+14 1 1.6060 0 xxxxxxxx 6.00e+00 xxxxxxxx 0.o0e+00
pb-209 1.17.+04 1 1.6000 0 xxxxxxxx 6.060+00 xxxxxxxx 6.600+00
pb-210 7.03e+08 1 1.6000 2 bi-210 4.33.+05 po-210 1.20.+7
bi-207 1.2090+9 1 1.6000 0 xxxxxxxx 6.600+00 xxxxxxxx 0.6000+
bi-20B 1.16.+13 1 1.0000 0 xxxxxxxx 6.66.+06 xxxxxxxx 0.0.00
bi-21e 4.33o+5 1 1.0000 1 po-210 1.20+07 xxxxxxxx 0.60+00
bi-210m 9.46.+13 1 1.0000 1 tl-206 2.52.+02 xxxxxxxx 0.000+00
po-2O9 3.22e+9 1 1.000 1 pb-265 4.420+14 xxxxxxxx 6.600+00
po-210 1.26+07 1 1.0660 0 xxxxxxxx 0.60.e+ xxxxxxxx 0.600+06
87
c step4gd computer code; cray fortran
C
c declaration of variables
real hf(259), b1brp(259), bldlhf(259),bld2hf(259),b2brp(259),
lb2dlhf(259),b2d2hf(259),dcflli(259),dcfsi(259).dcfst(259),
2dcfuli(259),dcfskl(259),dcflun(259).dcfov(259),dcfmar(259),
3dcftst(259),dcfthy(259),dcftb(259).lam(259).Itl(259).,t2(259),
4b21am2(259),b2laml(259).b212t1(259),sp8tp(259),spgbt(259),
4splS(259),sp7tp(259),sp7bt(259),sp17(259).sl8tp(259),
4s18bt(259),18(259).s17tp(259),s17bt(259),s17(259),s28tp(259),
4s28bt(259),s28(259).s27tp(259),s27bt(259),s27(259),
5b212t2(259),b2lltl(259),b211t2(259).blam2(259),bllam(259),
6b112t1(259),b112t2(259).bllltl(259),bllt2(259),b2e21(259),
7b2e22(259),b2el1(259),b2e12(259),ble2l(259),bI 22(259),
8b1e12(259),blell(259).gp(259,11),b2gd2(259.11),blgd2(259,11),
9sd38hsd37db2gdl(259,11),blgdl(259,11),sd28h,sd27d.sdl8h,
1sdl7dbr2d8h(259),br2d7d(259),brld8h(259),brld7d(259).
ld(259.3,11).cmf,smf,lam2,laml,gf,gff..pl(259),ep2(259),
2sd3fa,sd3fb,sd3fc,sd2fo,sd2fb.slf
integer count,blnd(259),b2nd(259),nbr(259)
charactereS iso(259).bldt(259),bld2(259),b2d1(259),b2d2(259)
C
C
call dropfile(O)
open(unit=2.fil.-'edrcf.3b',status-'old')
open(unit-3,file-'edrcf.4b',status-'old')
open(unit-4,file h'hflif 2',status-'old')
open(unit-5,file-'fourth'.status'unknown')
c
C
c initialize variables
sd38h - 0.0
sd37d - 0.0
sd28h - 0.0
sd27d - 8.0
sd18h - 0.0
sdl7d - 0.0
do 7 i-1,259
blbrp(i) - 8.6
b2brp(i) - 0.0
brld8h(i) - 0.6
brld7d(i) - 6.6
br2d8h(i) - 0.0
br2d7d(i) - 0.0
b1laml(i) - 0.0
b1lom2(i) - 6.0
b2lamt (i) 0 6.0
b21am2(i) 0 6.0
b2:11(i) - 6.0
b2412(i) - 0.0
b2 21 (i) - 0.0
b2e22(i) 0 6.0
bIe11(i)  0.0
ble12(i) - 0.0
ble21(i) - 0.6
b1e22(i) - 6.0
sp8tp(i) 9 6.6
sp8bt(i) 0 6.6
sp18(i) - 0.0
sp7tp(i) 0 6.6
sp7bt(i) - 0.6
sp17(i) = 0.0
sltp(i) - 6.6
s18bt(i) - 0.0
s18(i) - 6.0
s17tp(i) - 0.0
u17bt(i) - 0.0
s17(i) - 0.6
88
s28tp(i) = 0.0
s28bt(i) = 0.0
s28(i) = 0.0
s27tp(i) = 0.0
s27bt(i) = 0.0
s27(i) = 0.0
7 continue
c
c read hflife2 info
C
c skip top line
read(4,105)
105 format(74x)
C
do 10 i-1,259
read(4,115) iso(i),hf(i),nbr(i),blbrp(i),blnd(i),bldl(i),
lbld1hf(i),bld2(i),bld2hf(i)
115 format(o8,e10.2,2x.11,3x,F6.4,3x,I1,lx,o8,elO.2,lx,
1o8,e10.2)
if(nbr(i).ne.2) go to 10
read(4,125) b2brp(i),b2nd(i),b2dl(i).b2dlhf(i),b2d2(i),b2d2hf(i)
125 formot(24x,F6.4,3x,11,lx.a8,elO.2,lx,o8,elO.2)
10 continue
C
C
c read ground dose conversion factors
do 30 i-1,259
read(2,100) dcflii(i),dcfsi(i),dcfst(i),dcfuli(i),dcflun(i),
ldcfov(i)
read(3,110) dcfmar(i),dcfski(i),dcftst(i),dcfthy(i),dcftb(i)
100 format(36x,el.2,el.2,e10.2,elO.2,20x,elO.2,1ex,
lelO.2)
lie format(26x,elO.2,elO.2.10xe10.2,e10.2,30x,elO.2)
30 continue
c
c this section determines all of the lambdas of the parents,
c and their corresponding daughters and granddaughters.
c it also determines the dimensionless constants (lambdoetime)
c to be used in the exponential expressions.
c the maximum number that the computer con handle in on exp is
c 5500.0. the code sets 1/exp(It) - 0.0 if It > 550e.0.
C
do 15 i-1,259
lam(i) - log(2.O) / hf(i)
Iti(i) - lam(i) * 28800.0
It2(i) - Iom(i) * 604800.0
if(ltl(i).gt.5500.e) epl(i) - 0.0
if(It2(i).gt.5500.e) ep2(i) - 0.0
if(Itl(i).le.5580.0) epl(i) - 1 / exp(ltl(i))
if(It2(i).le.5506.S) ep2(i) - 1 / exp(It2(i))
sp8tp(i) - 1.0 - (epl(i) * epl(i) * epl(i) * epl(i))
sp8bt(i) - (epl(i) * ep1(i) * ep1(i)) + (epl(i) * epl(i)) +
lepi(i) + 1.0
sp18(i) = sp8tp(i) / sp8bt(i)
sp7tp(i) - 1.0 - (ep2(i) * ep2(i) * ep2(i) * ep2(i))
sp7bt(i) - (ep2(i) * ep2(i) * ep2(i)) + (ep2(i) - ep2(i)) +
lep2(i) + 1.0
spl7(i) - sp7tp(i) / sp7bt(i)
if(nbr(i).eq.2) go to 50
if(nbr(i).eq.1) go to 70
15 continue
go to 31
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50 if(b2nd(i).eq.0) go to 70
if(b2nd(i).eq.1) go to 55
b2lom2(i) - Iog(2.0) / b2d2hf(i)
b212t1(i) - b2)am2(i) * 28800.0
b2l2t2(i) = b2lam2(i) * 604800.0
if(b212t1(i).gt.5500.0) b2e21(i)
if(b2l2t2(i).gt.5500.0) b2e22(i)
if(b212t1(i). e.5500.0) b2e21(i)
if(b212t2(i).le.55e0.8) b2e22(i)
55 b2loml(i) - log(2.0) / b2dlhf(i)
b2l1tI(i) = b2lom1(i) * 28800.0
b211t2(i) - b2laml(i) * 604800.0
if(b2l1t1(i).gt.5500.0) b2ell(i)
if(b211t2(i).gt.5500.0) b2e12(i)
if(b2l1ti(i).le.5500.8) b2e11(i)
if(b211t2(i).Ie.5500.0) b2e12(i)
70 if(b1nd(i).eq.0) go to 15
if(blnd(i).eq.1) go to 75
bliam2(i) - log(2.0) / b1d2hf(i)
b1l2t1(i) = b1lam2(i) * 28800.0
b112t2(i) - bliam2(i) * 604800.0
if(bl12t1(i).gt.5500.0) ble2l(i)
if(b1l2t2(i).gt.5500.0) b1e22(i)
if(b1l2t1(i).l*.5500.0) ble21(i)
if(b112t2(i).le.5500.8) b1e22(i)
75 bilomi(i) - log(2.0) / bldlhf(i)
blllt1(i) - blaml(i) .28800.0
b1l1t2(i) - blaml(i) .604800.0
if(b1l1t1(i).gt.5500.e) ble11(i)
if(b 11t2(i).gt.5500.0) ble12(i)
if(billt1(i).le.5500.0) blell(i)
if(b1l1t2(i).le.5580.0) ble12(i)
go to 15
C
c
c
31 do 35 i-1,259
gp(i.1) - dcflun(i)
gp(i,2) - dcfmar(i)
gp(i,3) - dcfskl(i)
gp(i.4) = dcfst(i)
gp(i,5) - dcfsi(i)
gp(i,6) - dcfuli(i)
gp(i,7) - dcflli(i)
gp(i,8) - dcftst(i)
gp(i,9) - dcfthy(i)
gp(i.10) - dcfov(i)
gp(i,11) - deftb(i)
35 continue
C
0.00.0
1/ exp(b212t1(i))
1/ exp(b2l2t2(i))
- 6.0
- 0.0
- 1 /
- 1 /
- 8.8
- 1 /
- 6.0
- 1 /
exp(b2 lt1(i))
exp(b211t2(i))
exp(bil2t1(i))
exp(b112t2(i))
exp(bl 1t1(i))
exp(b11t2(i))
c BIG LOOP!! 7 day and 8 hr integrated dose calculations
c daughter and granddaughter contributions are included
c some isotopes have more than one pathway or "branch"
c that too is accounted for
C
C
do 1800 i-1,259
do 1005 j- 1,11
if(nbr(ii) .eq.2) go to 2000
if(nbr(i).eq.1) go to 3009
1005 continue
1000 continue
go to 6000
c isotopes with two branches
2000 count - 1
if(b2nd(i).eq.0) go to 2500
if(b2nd(i).eq.1) go to 2018
do 37 1-1,259
if(b2d2(i).eq.iso(l)) go to 2008
37 continue
print, 'SOMETHING IS WRONG'
stop
90
2008 b2gd2(i,j) - gp(I.j)
lam2 - b2tam2(i)
lami - b2Iaml(i)
c
s18tp(i) = 1.0 - (b2e11(i) s b2el(i) s b2e11(i) * b2ell(i))
si8bt(i) = (b2ell(i) * b2011(i) * b2eli(i)) +
1(b2ell(i) * b2ell(i)) + b2e11(i) + 1.0
s18(i) = sl8tp(i) / sl8bt(i)
si7tp(i) = 1.0 - (b2el2(i) 0 b2e12(i) * b2e12(i) * b2e12(i))
s17bt(i) - (b2e12(i) * b2e12(i) * b2e12(i)) +
1(b2el2(i) s b2e12(i)) + b2e12(i) + 1.0
s17(i) - sl7tp(i) / s17bt(i)
s28tp(i) = 1.0 - (b2e21(i) * b2e21(i) 0 b2e21(i) * b2e21(i))
s28bt(i) - (b2e21(i) s b2e21(i) * b2921()) +
i(b2e21(i) * b2e21(i)) + b2e21(i) + 1.0
s28(i) - s28tp(i) / s28bt(i)
s27tp(i) - 1.0 - (b2e22(i) * b2e22(i) * b2e22(i) * b2022(i))
s27bt(i) - (b2e22(i) s b2922(i) * b2e22(i)) +
1(b2e22(i) s b2e22(i)) + b2e22(i) + 1.0
s27(i) = s27tp(i) / s27bt(i)
gf - b2gd2(i,j)
go to 2300
2010 ca 47 1-1,259
if(b2dl(i).eq.iso(I)) go to 2612
47 continue
prints,'SOMETHING IS WRONG'
stop
2012 b2gdl(ij) = gp(.j)
lomi - b2loam1(i)
s18tp(i) - 1.0 - (b2.11(i) s b2ell(i) * b2ell(i) * b2ell(i))
sl8bt(i) - (b2e11(i) m b2ell(i) * b2ell(i)) +
1(b2e11(i) * b2ell(i)) + b2ell(i) + 1.,
s18(i) = sl8tp(i) / s18bt(i)
s17tp(i) - 1.0 - (b2e12(i) * b2e12(i) * b2e12(i) s b2e12(i))
sl7bt(i) - (b2e12(i) * b2e12(i) * b2@12(i)) +
1(b2e12(i) * b2e12(i)) + b2e12(i) + 1.0
s17(i) - sl7tp(i) / sl7bt(i)
gff - b2gdl(i,j)
go to 2450
2001 br2d8h(i) - sd38h + sd28h + sdl8h
br2d7d(i) = sd37d + sd27d + sdl7d
sd38h - 0.0
sd28h - 0.0
sd18h = 0.0
sd37d - 0.0
sd27d - 0.0
sdl7d - 0.0
3009 count - 0
if(blnd(i).eq.0) go to 2509
if(blnd(i).eq.1) go to 3010
do 56 1-1,259
if(bld2(i).eq.iso(I)) go to 3020
56 continue
prints,'SOMETHING IS WRONG'
stop
3020 blgd2(i.j) - gp(I.j)
lam2 - bllom2(i)
loml - blIaml(i)
sltp(i) - 1.0 - (blel(i) * ble( el(i) i) blell(i))
s18bt(i) - (bse11(i) b blell(i)) +
1(ble11(i) * ble11(i)) + b1e11(i) + 1.0
s18(i) - s18tp(i) / sl8bt(i)
s17tp(i) - 1.0 - (ble12(i) s ble12(i) * b112(i) s ble12(i))
s17bt(i) - (ble2(i) * ble12(i) s ble12(i)) +
1(ble12(i) s ble12(i)) + ble12(i) + 1.0
s17(i) = sl7tp(i) / sl7bt(i)
s28tp(i) - 1.0 - (b1e21(i) s ble21(i) s b1e21(i) * ble21(i))
s28bt(i) - (ble21(i) * ble2l(i) * ble2l(i)) +
1(ble21(i) e ble21(i)) + ble21(i) + 1.0
s28(i) = s28tp(i) / s28bt(i)
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s27tp(i) - 1.0 - (ble22(i) * ble22(i) * ble22(i) * ble22(i))
s27bt(i) - (ble22(i) * ble22(i) * ble22(i)) +
1(ble22(i) * ble22(i)) + ble22(i) + 1.0
s27(i) - s27tp(i) / s27bt(i)
gf - b1gd2(ij)
go to 2300
3e1e do 67 1=1,259
if(b1d1(i).eq.iso(I)) go to 3015
67 continue
print*, 'SOMETHING IS WRONG'
stop
3015 blgdl(i,j) = gp(l.j)
Iom1 - blaml(i)
sl8tp(i) - 1.0 - (blell(i) * ble1l(i) * ble11(i) * blel(i))
s18bt(i) - (blell(i) * blell(i) * b111(i)) +
1(ble11(i) * ble11(i)) + blell(i) + 1.0
s18(i) - sl8tp(i) / si8bt(i)
sl7tp(i) - 1.0 - (be12(i) * ble12(i) * ble12(i) * ble12(i))
s17bt(i) - (ble12(i) * ble12(i) * ble12(i)) +
1(ble12(i) * ble12(i)) + ble12(i) + 1.0
s17(i) - s17tp(i) / sl7bt(i)
gff - blgdl(ij)
go to 2456
3001 brld8h(i) - sd38h + sd28h + sd18h
brld7d(i) = sd37d + sd27d + sd17d
sd38h - 9.0
sd28h - e.0
sd18h = 0.0
sd37d - 0.0
sd27d - 0.0
sd17d - 0.0
d(i.1,j) - blbrp(1) * brld~h(i) + b2brp(i) * br2d8h(i)
d(i.2,j) - blbrp(i) * brld7d(i) + b2brp(i) * br2d7d(i)
go to 1005
C
c
c
c
c
c subdose3 - dose from granddaughter
c 8 hr and 7 day
2300 sd3fo = (Iam2 * loel) / (lom(i) * (lami - lom(i)) *
1(lam2 - lom(i)))
sd3fb l Iom2 / ((Iam2 - laml) * (lo11 - lam(i)))
sd3fc - lomi / ((Iam2 - lami) * (lam2 - Iam(i)))
sd38h - ((sd3fa * sp18(i)) - (sd3fb * s18(i)) +
1(sd3fc * s28(i))) $ gf
sd37d - ((sd3fa * sp17(i)) - (sd3fb * s17(i)) +
1(sd3fc s .27(i))) * gf
sd3fa - 0.6
sd3fb - 0.0
sd3fc - 0.0
if(count.eq.1) go to 2610
go to 3010
c subdose2 - dose from daughter
2450 sd2fa - lomi / lam(i)
sd2fb - 1 / (lam1 - lam(i))
sd28h - ((sd2fa * sd2fb * splS(i)) - (sd2fb e s18(i))) * gff
sd27d - ((sd2fa * sd2fb * sp17(i)) - (sd2fb * s17(i))) * gff
sd2fo --0.0
sd2fb - 0.0
c subdosel - dose from itself
2506 s1f - 1 / lam(i)
sd18h - gp(i.j) * slf * sp18(i)
sd17d - gp(i,j) * slf * sp17(i)
if(count.eq.1) go to 2001
go to 3001
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c
C
C
c converting from (rem/s)/(ci/m2) to (rem/yr)/(ci/m2)
6000 smf - 3.1536e+07
do 90 i-1.259
do 95 j=1.11
d(i,3.j) - gp(ij) * smf
95 continue
90 continue
C
C
C
c writing to fourth
write(5,350)
350 formot(' NUCLIDE ','TIME INDEX',' LUNG ,' MARROW
1' SKELETON ,' GI:ST ',' GI:SI ',' GI:ULI ,' GI:LLI
2' TESTES ' THYROID ', OVARIES ',' TOT BODY ')
do 145 i-1,259
do 155 j-1,3
if(j.eq.1) write(5,406) iso((ij ,j k), k-1 11)
if(j.ne.1) write(5,408) j,(d(i,j,k), k=1,11)
406 formot(o8,2x,5x,I1,4x,lpelO.2,lpel.2,1pe10.2.1plO.2.1pe16.2,
lpe1.2,lpel.2,lpel.2,ipe10.2,lpel. 2 ,1pe10.2 )
408 formot(10x,5xI1,4x,lpe18.2,1pe18.2,1pe18.2,1pe18.2,lpelO.2,
lpel.2,1pele.2, lp.1.2,lpelB.2 ,lpe18.2,lpel.2)
155 continue
145 continue
stop
end
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c step5 computer program; croy fortran
C
c this program writes all of the information to fusdos from all
c of the other sub-files, namely, second, third, and fourth.
c The name of the file for now will be fdtrl, standing for fusdos-
c t rial 1.
C
c note: something will have to be done about the e notation. The
c old fusdos has e10.4 format. However, fetter's files had e19.2.
c Thus for now, fdtrl will have e10.2 format. We can change the way
c fusdos-is read in fuscr3 at format statement 201, which now reads
c (7e10.4/4e10.4). We can change this to (11e10.2).
c
c regarding the above comment; FUSCRAC3 was changed so that it readC in 11010.2 format.
c
C
real inl(1,7.259),incon(11,7,259),grcon(11,3,259),clcon(11,259)
integer isonum,time
character*8 iso(259), orgnam(11)
c
c
call dropfile(O)
open(unit-2,file-'second',status-'old')
open(unit-3,file-'third',status-'old')
open(unit-4,file-'fourth',status-'old')
open(unit-5,file-'fusdos3',status-'old')
open(unit=6,file-'fdtrl',status-'unknown')
open(unit-7.file-'second2',status-'unknown')
C
C read in isotope names
read(5,18e) (iso(i),i-1,259)
186 format(18a8)
c read inhalation dose conversion factors
c skip top line
read(2,90)
90 format(130x)
c
c234567
do 10 k-1,259
do 11 j-1,7
read(2,104)(inl(i.j.k), i-1,11)
c NOTE: THESE 7 TIME PERIODS ARE 6-ACUTE TIME PERIOD, 8-1. 6-10
c 0-2e,0-30.6-40, AND 6-50
100 format(29x.11e10.2)
11 continue
16 continue
c
C read ground dose conversion factors
c
c skip top line
read(4.90)
c
do 20 k-1,259
do 21 j-1.3
read(4,110)(grcon(i j.k). i-1,11)
116 format (20x,11e10.2)
21 continue
20 continue
c
c read cloud dose conversion factors
c
c skip top line
read(3.90)
c
do 30 k-1,259
read(3.120)(clcon(ik), i-1,11)
120 format(10x,11e1.2)
30 continue
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c assigning orgnomes to orgnam array
orgnam(1) - 'lung
orgnam(2) - 't marrow'
orgnam(3) = 'skeleton'
orgnam(4) = 'st wall
orgnam(5) - 'si+cont
orgnam(6) - 'uli wall'
orgnam(7) - 'Ili wall'
orgnam(8) - 'testes
orgnam(9) a 'thyroid
orgnom(10) = 'ovaries
orgnam(11) - 'w body
c
c
c
C
c
c
240
230
220
C
c
NOTE: FOR INHALATION:
THE TIME PERIODS 3 THROUGH 7 MUST BE CHANGED TO 1-10,10-20,2e-30,
30-40, ANL 40-50. TIME PERIODS 1 AND 2 REMAIN THE SAME.
do 220 k-1.259
do 230 i-1,11
incon(i,1.k) - inl(i,1,k)
incon(i,2,k) - inl(i,2,k)
do 240 j-3.7
m M j - 1
incon(i,j,k) - inl(ij,k) - inl(i,m.k)
continue
m r a
continue
continue
c writing to fdtri
write(6,140) (iso(i), i-1,259)
140 format(10a8)
do 85 i-1,11
write(6,150) orgnam(i)
150 format(a8)
write(6,160)((incon(itimeisonum). time-1,7),
1(grcon(itimeisonum), time-1,3). clcon(i.isonum), isonum-1,259)
160 format(lpe10.2,lpelO.2.1pe10.2.lpelO.2,lpelO.2,lpe19.2.1pelO.2.
1lpelO.2,lpe10.2,lpelO.2.lpelO.2)
85 continue
C
c i will write to a file called second2 for the purpose of observing
c more closely the inhalation dose conversion factors, particularly
c because of the correction due to the time periods.
c
320
310
300
303
500
600
35
25
do 300 k-1.259
do 310 i-1,11
do 320 j-1,7
inc(i,jk) - incon(i,j,k)
continue
continue
continue
write(7,303)
format(' NUCLIDE '.'TIME INDEX'.' LUNG ',' MARROW
1' SKELETON ',' GI:ST ', GI:SI GI:ULI ',' GI:LLI
2' TESTES '.' THYROID ,' OVARIES ',' WH BODY ')
do 25 k - 1,259
do 35 j - 1.7
if (j.eq.1) write(7,500) iso(k) j,(inc(i,j.k), i-1,11)
if (j.ne.1) write(7,600) j,(inc(ij,k), i-1,11)
format(o.2x,5xIi.4x,1pelO.2,lpelO.2,1peO. 2.lpelO.2,
1lpet1.2,lpelO.2.lpe19.2.pelO.2,lpelO.2,pe10.2,1pe10.2)
format(1Ox,5x.I1.4xlpelO.2,lpel1.2.lpet1.2,1pe10.2.
Ilpe10.2.lpelB.2.1p10.2,lpelO.2.lpe19.2,lpel.2,lpel.2)
continue
continue
stop
end
95
c step6 computer code; cray fortran
c
c this code reads in the necessary ingestion dose conversion factors
c from Fetter's files. The times of interest are: 0-5e.0-10,10-20,
c 20-30.30-40, and 40-50.
C
c
c234567
c declare variables
real ing1(259,9,11),ing(259,6.11),dcfl i(259,9),dcfsi(259,9),
ldcfst(259,9),dcfuli(259,9),dcflun(259.9),dcfov(259,9),
ldcfmar(259,9),dcfskl(259,9),dcftst(259,9),dcfthy(259,9).
ldcfwb(259,9)
charactereS iso(259)
c
call dropfile(O)
open(unit-2,file-'idcf.3nb',status-'old')
open(unit-3,file-'idcf.4nb',status-'old')
open(unit-4,file-'ingest',sttus-'unknown')
open(unit-5,file-'fusdos3',status-'old')
c
c red in isotope names
reod(5,180) (iso(i), i=1,259)
18 format(loS)
c234567
c skip top lines in both files
90
c
108
lie
15
lS
c
c
read(2,90)
read(3,90)
format(130x)
do 10 i-1,259
do 15 j-1.9
read(2,109) defili(ij).defsi(i,j).dcfst(i,j),dcfuli(ij),
ldcflun(i,j),dcfov(i,j)
read(3,110) dcfmar(i,j),dcfski(i,j),dcftst(ij).dcfthy(i .j),
ldcfwb(i, j)
format (40x.4e10.2.20x,elS.2,10x,elS.2)
format (30x,2e10.2,lx,2e10.2,20xe10.2)
continue
continue
do 25 i-1,259
do 30 j-1,9
ingl(i,j,1) - dcflun(i.j)
ingl(ij,2) - defoar(i.j)
ingl(i,j,3) - dcfskl (i,j)
ingl(i.j,4) = defst(ij)
ingl(ij,5) - dfsi(i,j)
ingq(i,j,6) defuli(i,j)
ingl(i.j,7) dflli(ij)
ing1(i.j.8) dcftst(i.j)
ingi i.j,9) - defthy(i,j)
ingi(i.j,1O) - dctov(i,j)
ing1(ij.11) - dcfwb(i,j)
30 continue
25 continue
do 50 i-1,259
do 60 k-1,11
ing(i,1,k) = ingl(i,9.k)
ing(i,2,k) - ingl(i.5,k)
do 65 .1-3,6
j I + 3
m rI + 2
ing(iI,k) - ingl(i.j,k)- ingl(i.m.k)
65 continue
j
m
60 continue
50 continue
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writing to ingest
write(4,147)
147 format(' NUCLIDE ','TIME INDEX',' LUNG ',' T kRROW
1' SKELETON , ST WALL ',' SI+CONT ',' ULI WALL , LLI WALL
2' TESTES ',' THYROID '' OVARIES ', W BOD ')
do 105 i-1,259
do 115 j-1,6
if(j.eq.1) write(4,150) iso(i),j.(ing(i.j.k), k-1,11)
if(j.ne.1) write(4,160) j,(ing(i,j,k), k-1,11)
150 format(a8,2x,5x,11,4xlpelO.2,lpelO.2,lpelO.2,1pe10.2,
1lpelO.2,lpelO.2,1pe10.2,lpele.2,lpelO.2,1pe10.2,1pe10.2)
160 format(10x,5x,I1,4xlpelO.2,lpelO.2,lpele.2,lpele.2,lpele.2,
1ipelO.2,1pelO.2,1pelO.2,1pelO.2,1pelO.2,1pelO.2)
115 continue
105 continue
stop
end
C
C
c
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Appendix C
CREATION OF THE OUTPUT FILE FUSFET.0
Definitions of important variables:
k: spatial interval; k=2 corresponds to 1 km; k=10 corresponds to
10 km
labd: label variable
1sec: sector number; sector of interest = #1
wb: whole body
ires: result number: 6 corresponds to total latent effects from initial
plus chronic exposure
7 corresponds to the total whole body man rem
19 corresponds to the total effects to the whole
body, where the whole body is treated as a
single organ
Note: The single quotes that appear in the format statements were needed so
that when the output files were downloaded from the Cray to an IBM
PC, the single quotes were easily changed to double quotes uniformly
by the KEDIT processor. The files were then transferred to Lotus and
treated as numerical files.
98
line no. coding
in the
tedi editor
731 c
* 732 call open(47,'fusfet.o',2,Ien)
* 733 call skipeof(47,1)
* 734 bockspace(47)
735 c
1091 write (not,60) id,icd
* 1092 write (47,61) id,icd
1093 60 format (1hO,10x,18a4,7x,a1,//)
* 1094 61 format ('".,12a4,"'",7x,al)
1095 c
4934 if(nph It. 3) go to 715
4935 if(nic.eq.1 or. nlc.eq.2) go to 715
4936 write(not,635)
4937 635 format(///,20x,"latent effects from chronic exposure",/)
* 4938 if((k.ne.2).and.(k.ne.8)) go to 8906
* 4939 write(47.8635)
* 4940 8635 format(///,20x,''latent effects from chronic exposure'",/)
4941 c check for interdiction
* 4942 8906 if(timek .1e. 10950.) go to 715
5778 c
5779 c print heading for health effects if nph>0
5780 if(nph.ge.1) write(not,2001) k
5781 if(nph.ge.1) write(not,2003) il
* 5782 if(k.eq.2) write(47,8001) k
* 5783 if(k.eq.2) write(47,8003) il
5784 c
5882 c erlinj is the total probability of occurence of an injury
5883 if(fatfac(iearly) .It. 1.0) erlinj(il) - erlinj(il) +
5884 1 pb(iearly,il) * (1. - erlinj(il))
5885 if(nph.ge.1) write (not,2000) erlorg(iearly),pb(iearly,il),
5886 1 totdos(iearly,il),cloud(iorg).ground(iorg),breath(iorg),
5887 2 fatal(il),erlinj(iH)
* 5888 i.f(k.eq.2) write(47,8000) erlorg(iearly),pb(iearlyil),
* 5889 1 totdos(iearly.il),ctoud(iorg),ground(iorg).breath(iorg),
* 5890 2 fatal(il),.rlinj(iI)
5912 c
5913 c print heading for detailed output
5914 if(nph.ge.2) write(not,2002)
* 5915 if(k.eq.2) write(47,8002)
* 5916 if(k.eq.8) write(47,8002)
5917 c
* 4454 real labd(4)
* 4455 real wb
* 4456 data wb /6hw body/
* 4471 data labd /8h'inh ds ,8h'ing ds ,8h'grd ds',7h'cases'/
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line no. coding
in the
tedi editor
5040 if(nph .e. 2) go to 1710
5041 write(not,1800) loorg(lorg),Iaeff(lorg),k,Isec
* 5042 if((k.ne.2).and.(k.ne.8)) go to 8901
* 5043 if(lsec.ne.1) go to 8901
* 5044 if((Iaorg(lorg).ne.wb).or.(laeff(lorg).ne.wb)) go to 8901
* 5045 write(47,8808) laorg(lorg), laeff(lorg),k,lsec
* 5046 8901 if(lsec .eq. 1) write(not,1801)
5047 1 alabel(1),ibi,(temcl(itimelorg),itime-1,10),
5048 2 alabel(2),ihm,(temc2m(itimelorg),itime-1,10),
5049 3 olabel(2),ihc,(temc2c(itime, lorg),itime-1,10),
5050 4 alobel(3),(temc3(itime.lorg),itime-1,10)
* 5051 if((k.ne.2).and.(k.ne.8)) go to 8931
* 5052 if(Isec.ne.1) go to 8931
* 5053 if((laorg(lorg).ne.wb).or.(laeff(lorg).ne.wb)) go to 8931
* 5054 write(47,8801)
* 5055 1 labd(1),ibl,(temcl(itimeiorg),itime-1,10),
* 5056 2 tabd(2),ihm,(temc2m(itimelorg),itime-1,10),
* 5057 3 lobd(2),ihc,(temc2c(itime, lorg),itime-1,10),
* 5058 4 labd(3),(temc3(itimelorg).itime-1,10)
* 5059 8931 write(not,1802) alabel(4), (totchr(lorgitime),itime-1,10)
* 5060 if((k.ne.2).and.(k.ne.8)) go to 1710
* 5061 if(Isec.ne.1) go to 1710
* 5062 if((loorg(lorg).ne.wb).or.(laeff(lorg).ne.wb)) go to 1710
* 5063 write(47,8802) labd(4),(totchr(lorg,itime),itime-1,10)
5064 1800 format(10h organ is a8,13h effect is ,a8,11h interval,i3,
5065 1 131n and sector ,i3)
* 5066 8808 format(10h'organ is ,a8,13h' 'effect is ,o8,llh' 'interval,i3,
* 5067 1 lh',13h' and sector ,i3,1h')
5068 1801 format(3(lx,o8,lx,al,lplOell.3/),lx.o8,2x,lplOell.3)
5069 1802 formot(1x,a5,5x,1p1Oe11.3/)
* 5070 8801 format(3(lx,o8.lx,a,"'",1pleell.3/),lx,a8,2x,lplOell.3)
* 5071 8802 format(1xa7,3x,1plOe11.3/)
5072 c
* 5073 1710 continue
* 5737 real labd(3)
* 5738 real wb
* 5739 data wb /6hw body/
* 5745 data labd /"'cl,grd'","'inh d5'","'cOse/p'"/
6083 c print results for this organ if requested
6084 if(nph.1t.2) go to 720
6085 write(not,2005) laorg(ila),Iaeff(ila),cloud(iorg),ground(iorg)
6086 write(not,2010) alabel(2), (airin(i), i-1,intime)
6087 write(not.2010) alabel(3),
6088 1 (tot lat(ila,itime), itime-1,intime), totorg(i Ia)
* 6089 if((k.ne.2).and.(k.ne.8)) go to 720
* 6090 if((laorg(ila).ne.wb).or.(Iaeff(ila).ne.wb)) go to 720
* 6091 write(47,8005) laorg(ila),laeff(ila),cloud(iorg),ground(iorg)
* 6092 write(47,8010) labd(2), (airin(i), i-1,intime)
0 6093 - write(47,8010) labd(3).
* 6094 1 (totlat(iIa,itime),itime-1,intime),totorg(iia)
* 6095 720 continue
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6097 c
6098 2000 format(" ",o8,3x,1p7e11.3)
* 6099 8000 format(" ","'",o8."'",3x,1p7e11.3)
6100 2001 format("1",20x,"* * * s * health effects detailed output -
6101 1 "spatial interval number =,3," * * * *",//)
* 6102 8001 format("'1".20x,"' * s o * health effects detailed output -
* 6103 1 "spatial interval number -",i3," s * '
6104 2003 format(20x,"acute effects from early exposure, evacuation
6105 1 scheme". i3,//,1x,"organ prob total ds cloud ds
6106 2 ground ds inhol ds cum",
6107 4 "fatal cum injur",/)
* 6108 8663 format(20x,"'acute effects from early exposure'",
* 6109 1 i3,//.1x,"'organ' 'prob' 'total ds' 'cloud ds'
* 6110 2 'ground ds' 'inhal ds' 'cum",
* 6111 4 "fatal' 'cum injur'",/)
6112 2002 format(///,20x."lotent effects from early exposure",/)
* 6113 8002 format(///,20x."'latent effects from early exposure'"./)
6114 2005 format(" ","ergan is ",a8," effect is ",a8," cloud ds =",
6115 1 1pe10.3," ground ds -",1pelO.3)
* 6116 8005 format(" ","'organ is ".8."'","'effect is ".a8,"'",
* 6117 1 "'cloud ds -'",1pelO.3,"'ground do -'",1pe19.3)
6118 2006 format("1",20x,"isotope percentage contribution to dose",//,
6119 1 lx,"isotope ",8(7x.a8))
6120 2007 format(15x,8(al,"dose",4x,"O".5x)./)
6121 2008 format(lxa8,2x,8(fl0.2,lx.f4.1))
6122 2009 format(lx,"total ",2x,8(flO.2,5x))
6123 2010 format(" ".a8,11(1pe11.3))
* 6124 8010 format(" ",a8,11(lpell.3))
7941 write(not,960)
* 7942 write(47,9601)
7943 if(nI eq. np2pl) write(net,960)
7944 ip2=0
7945 7500 continue
7946 ires-i
7947 if(nevoc .eq. 1) ires-i - neres
7948 ip1 - ipi + 1
7949 ip2 - ip2 + 1
7950 write(not,980) ires,(resnam( ,ii),1-1,2),(resu(iiiin),in-1,5),
7951 1 itrial,itimeibin
* 7952 if((ires.ne.6).and.(ires.ne.7).and.(ires.ne.19)) go to 7777
* 7953 write(47.9801) ires.(resnam(l.ii),1-1,2),(resu(iiiin),in-1,5),
* 7954 1 itrial.itime.ibin
s 7955 7777 if(ni.eq.np2pl) write(net,980) ires.(resnam(Iii).lm1,2),
7956 1 (resu(iii.in),in-1,5),itrialitime.ibin
7957 7000 continue
8056 960 format(/,
8057 1 5x,"ss description *a **s mean *** * variance * s p(not 0)
8058 2 "," * *so peak ** ** p(peak) o *****s* trial ***s**.*")
o 8059 9601 format(/,5x,
* 8060 1 " ' ''**description**' '** mean *.' '*variance*' '.p(not 0)'
* 8061 2 ","'o *. peak **''** p(peak) a''.a*aasaa trial .. aa...'")
8062 980 format(lx,i3.lx,2a8,3xlpelO.2,4(4x.lpel0.2),5x.i8,i8,i3)
s 8063 9801 format(lxi3,lx, "'", 2a8,"'",3x,1pe1.2,
8064 1 4(4x,lpe1.2),5xi8.i8,i3)
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THE FOLLOWING IS A SAMPLE OUTPUT FILE CREATED BY THE ADDITIONS NOTED
A8OVE.COMOINED WITH THE DATA FROM FETTER-S ESECOM FiLES, AND MANIPULATED
USING IBM LOTUS.
ISOTOPi - 00-210 AMiOMUT RELEASE0 - 1 Ci 2,3,5,6,0
Xe@cwto FUSCRAC3
** I km ivfo: ...
acut* effects from earty exposure
organ
t morrow
Lii we
Iung
W body
pro
0.0006+00
0.0004.00
0.0006.00
0.0001+00
totet as cloW do grouni do ineiet do ciafetat CA injur
3.4631-04
5.564-04
1.3071-01
8.0529-04
1.5221-11
8.7996.12
1.2346-11
1.3151-11
4.5072-09
2.5896-09
3.6751-09
3.8036-09
3.46N-04
5.5641-04
4.30?6-01
6.0526-04
0.0001+00
0.000000
0.000600
0.0001+00
0.0001+00
0.0001+00
0.0006+00
0.0006+00
latent effects from earLy exposure
organ is w bodyeffect is w bodta d as a
imn as 1.2316-02 0.0006.00
case/p 1.9436-06 0.0006+00
Latent effects from cheonic *xposure
ogaw is w bo*effect is w begintervat 2
iem d 1.3532-03 1.2169-02
ins do a 1.671100 1.5101.01
in, do e 7.969-02 7.172.01
ge do 3.6111-08 1.6172-09
cases 1.9906-03 1.7916-02
.m 10 km info: *
Latent effects frm earty exposure
organ is w bedyeffect is a bhsIoatd as s
ii 'f as.5441-04 0.0006.00
case/p 1.3496-0? 0.0001.00
1.3156-11 grund doal
0.0006.00 0.0006.00
0.0001+00 0.0001.00
and sector
2.1621-13
3.079-25
1.421-26
1.4171-09
8.5956-14
3.8.5-09
0.0006.00 0.0006.00
0.000600 0.0001+00
0.000+00 0.000100
3.0711-25 3.0791-29
1.66U-26 1."11-26
1.4171-09 0.0004+00
8.596-14 3.65 -28
1.1056-12 geraW do a0 2.697-1
0.00640+0 0.0000 0.0006100
0.000600 0.0001+00 0.000+00
0.000400
3.0741-25
1.2461-ad
0.000600
3.6521-u3
0.000100 0.0001-00
0.0001-00 0.0001.00
2.9221-U
7.6841-26
3.6241-27
0.000600
1.7121-26
2.921- 22
7.6861-f6
3.6244-27
4.13"1-24
1.807E-26
0.0006.00 0.0006.00 0.0006.00
0.0001+00 0.0001.00 0.0006.00
tOt Lot art: 8.5441-04
tatent Offets frm chronic easee
organ is a boeyffect is a bedintervet a wd sleatr 1
in do 9.3161-05 8."71-06 1.5011-14 0.0006401 0.0006+00 0.0001+00 2.0396-33 2.0291-23
in, as a 1.1661-01 1.049400 2.1316-26 2.130-6 2.13M -26 2.1311-6 5.3361-27 5.33I6-Z?
in, da e 5.5344-03 4.90-02 1.0156-3? 1.015-i 1.0156-37 1.0151-27 2.5171-3U 2.517E-23
geI do 2.5136-09 9.43m-11 9.M31.11 9.23M-11 0.001140 0.000000 0.000600 2.8721-5
ces 4.0596-0 3.66-03 1.753-14 1.7536-14 7.6411-Z9 7.6111-39 3.6361-27 3.6851-27
tot ire: 1.22m-01 1.091 2.2401-26 2.21-21 3.2611-21 2.240-21 5.511-21 5.5111-27
irA e gIrd: 9.3161-05 8.6671-0 9.864-11 9.231-11 0.0001+0 0.000100 2.0196-n3 2.051-23
tot chron: 1.2216-01 1.100600 9.864-11 9.8311-11 .340-26 2.240-21 2.030-23 2.0511-23
inget;S0yrs, 9.3861-04
inrAged;soyr" 
tot tat rtLs I.7936-03
chron 50 yre: 1.222+0o
chron 50 yrs +
tot tat ort: 1.2236+00
*aseriptfin mean "
6.0006.00 tot tat/totae 1.406100
7.0006+00 tot wieay iere 3.6306.04
1.9006.01 totL a NsY 5.7406+00
*verteies *sPret 0) " sago
0.000640 1.00010 1.40600
0.0006.0 1.000100 3.6M04
0.0006.00 1.000600 5.7401400
SO(se) * * t"" i r st
1.0 +600 1.0101+06 4.0016.05
1.000100 1.0101+06 4.0016+05
1.000040 1.0106106 4.0016.05
FITTER'S 66 s6S
Activity
Retessal
mugtlde (Ci)
PO-210 1.060602
CriticlL
Doe (1 km)
(ren)
5.1106-01
Chronee
Does (10 to)
(fr")
2.74011.01
Critical
Des (1 ka)
(sCl)
4.11216-03
Choenie
Dese (10 kn)(e-C1)
2.585-03
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Appendix D
REM/CI DATA FOR ALL 259 ISOTOPES
The following is a presentation of the rem/Ci data generated from
pessimistic release assumptions as specified in Section 4.1, and as listed at the
beginning of the following table. Because of the enormous quantity of data, it
was decided tht the following was the optimal presentation of the data, allowing
for the complete, uncut information while maintaining readability.
The column labels require further explanation, which is given below:
PROMPT DOSE AT 1 KM:
WB:
The dose delivered to a particular
organ at 1 km from the release, from
cloudshine during plume passage, 7
days of groundshine, and the dose
commitment over an organ-dependent
critical acute time period from
inhalation during plume passage
Whole body, tacute = 2 days
BM:
LLI:
Lung:
FETTER WB:
WB EARLY DOSE:
WB CHRONIC DOSE AT 1 KM
AND AT 10 KM
Bone marrow, tacute = 7 days
Lower large intestine, tacute = 7 days
Lung, tacute = 1 year
Fetter's critical whole body dose at 1
km, where the critical dose is that
dose delivered from cloudshine and
groundshine during a 10-hour plume
passage, plus the dose due to
inhalation during a 10-hour plume
passage delivered over the first 7 days
after initial exposure plus one-half the
dose delivered over the next 23 days
The whole body early dose, where
early dose is the dose from initial
exposure; i.e., cloudshine during plume
passage, 7 days of groundshine, plus
the 50-year dose commitment from
radioactivity inhaled during plume
passage; differs from prompt because
the inhalation commitment is over a
longer time period
The whole body dose at 1 km/10 km
from the release due to both initial
exposure and chronic (50 year)
exposure:
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Inh+grd:
Ing:
Total:
Fetter WB at 10 km:
CANCERS:
CANCERS:
Sum Organs
WB
WB: Man-rems
Chronic exposure considers the
50-year groundshine exposure plus the
50-year dose commitment from
inhaled resuspended radioactivity.
Ingestion is not included. (This
corresponds to Fetter's definition of
whole body chronic dose.)
Chronic exposure considers the
ingestion pathway only.
Chronic exposure considers all three
pathways: resuspension, groundshine,
and ingestion.
Fetter's whole body chronic dose at
10 km, which includes the dose due
to initial plume exposure plus
groundshine and resuspension over a
50-year chronic exposure period.
(See the above definition of "WB
CHRONIC DOSE AT 10 KM:
Inh+grd".) Note that Fetter's chronic
dose does not account for ingestion.
Total number of cancers in a 50-mile
radius from initial and chronic
exposure, where the body is treated as
a sum of individual organs and
calculations are based on organ-
specific dose factors and dose
responses.
Total number of cancers in a 50-mile
radius from initial and chronic
exposure, where the body is treated as
a single organ and the whole body
dose conversion factors and dose
response are used.
Total whole body man-rem due to
both initial exposure plus an 80-year
chronic exposure to the whole body -
this is a population dose.
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Appendix E
INVESTIGATION OF THE EFFECT OF GROUNDSHINE EXPOSURE TIME
ON THE CRITICAL DOSE
As was mentioned in Section 4.2.2, the effect of groundshine exposure time
was investigated for 10 isotopes, which were of interest due to their large
contributions to the overall dose (mobility categories I-V) for one or more of the
seven designs. The motivation behind this analysis was the discovery of the large
difference in groundshine exposure times used by FUSEDOSE (10 hours) and
FUSCRAC3 (7 days = 168 hours). Consequently, FUSCRAC3 was re-run for a 1
Ci release of each of the 10 isotopes, using a groundshine exposure time of 10
hours. The results of these runs are presented in Table E.1. As can be seen
from the data in the table for each isotope, a 10-hour groundshine exposure time
yielded overall critical doses less than a factor of 2 greater than those generated
by FUSEDOSE, while the original doses calculated using a seven-day exposure
period were up to factors of 15 and 16 greater than Fetter's FUSEDOSE
numbers. As a result, the critical-dose TDRFs for mobility categories III-V (the
majority of the dose in categories I and II comes from inhalation-dominated
isotopes) are significantly greater than the original values. In fact, as can be seen
in Table E.2, the new TDRFs are only approximately a factor of 2 lower than
those calculated by Fetter for the majority of cases. The only significant
differences occur in the mobility category summation I-IV for the first wall for
Case 4, where FUSEDOSE's TDRF is still - 23 times greater than FUSCRAC3's,
and for Case 7, where FUSEDOSE's TDRF is still ; 13 times greater than
FUSCRAC3's. This is easily explained by the fact that the major isotope of
interest in categories I-IV for the first wall for Cases 4 and 7 is Cr-51, which is
also groundshine-dominated. But because Cr-51 is not a large contributor to the
total overall dose (i.e., I-V) for any of the designs, its total critical dose was not
recalculated. It is certain that such a recalculation would yield a much lower
dose from Cr-51 and hence a much larger TDRF value from FUSCRAC3 for
Cases 4 and 7, mobility categories I-IV, first wall.
In examining Table E-1, one sees a slightly disturbing result: the total
critical dose for Mn-56 increases slightly with the decreased exposure time. This
apparent inconsistency is explained by the fact that Mn-56 has a relatively short
half-life (0.11 days), which is about 5 times less than the next shortest half-life
of the 10 isotopes in the table. (Cu-64 has a half-life of roughly 0.53 days.)
This factor is important because the interpolation routine used by FUSCRAC3 is
non-linear. FUSCRAC3 interpolates between the Values given in the health file
(FUSDOS3); that is, the 8-hour integrated groundshine dose conversion factor and
the 7-day integrated groundshine dose conversion factor. For Mn-56, the total
groundshine dose is an extremely slowly increasing function of exposure time, since
most of it has decayed away after 8 hours. Hence, it is most likely that the
non-linear interpolation routine used by FUSCRAC3 over-estimates the dose for
exposure times -between 8 hours and 7 days for short-lived isotopes.
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